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Visualizing genetic changes throughout tissues can explain basic biological functions 
and molecular pathways in disease.  However, over 90% of mammalian messenger 
RNA (mRNA) is in low abundance (<15 copies per cell) making them hard to see 
with existing techniques, such as in-situ hybridization (ISH).  In the example of 
diagnosing cancer, a disease caused by genetic mutations, only a few cancer-
associated mRNAs can be visualized in the clinic due to the poor sensitivity of ISH.  
To improve the detection of low-abundance mRNA, many researchers combine the 
cells across a tissue sample by taking a scrape.  Mixing cells provides only one data 
point and masks the inherent heterogeneity of tissues.  To address these challenges, 
we invented a sensitive method for mapping nucleic acids across tissues called 2D-
PCR.  2D-PCR transfers a tissue section into an array of wells, confining and 
separating the tissue into subregions.  Chemical steps are then used to free nucleic 
acids from the tissues subregions.  If the freed genetic material is mRNA, a 
purification step is also performed.  One or more nucleic acids are then amplified 
using PCR and detected across the tissue to produce a map.  As an initial proof of 
concept, a DNA map was made from a frozen tissue section using 2D-PCR at the 
resolution of 1.6 mm per well.  The technique was improved to perform the more 
challenging task of mapping three mRNA molecules from a frozen tissue section.  
Because the majority of clinical tissues are stored using formalin fixation and not 
freezing, 2D-PCR was improved once more to detect up to 24 mRNAs from formalin-
fixed tissue microarrays.  This last approach was used to validate genetic profiles in 
human normal and tumor prostate samples faster than with existing techniques.  In 
conclusion, 2D-PCR is a robust method for detecting genetic changes across tissues 
or from many tissue samples.  2D-PCR can be used today for studying differences in 
nucleic acids between tumor and normal specimens or differences in subregions of 
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Chapter 1: Motivation and Background 
 
In molecular biology research and clinical diagnosis, there is a need for a robust 
method that can detect and quantify nucleic acids across tissue samples.  A robust 
technique is one that works sensitively, quickly, consistently, and in a way that is 
compatible with a wide range of specimens and molecular targets.  Current 
techniques do not address this need.  This dissertation establishes a new technique, 
2D-PCR, for mapping nucleic acids across tissue samples robustly. 
 
1.1 Introduction 
There is a vast potential resource of biological information in human tissue samples, 
including about 20,500 genes1 and about 1000 known microRNAs2.  Identifying how 
genes (nucleic acids) change in space and time can explain normal biological 
processes or the development of disease.  Genetic patterns can also provide novel 
starting points for medical therapy3, 4.   
 
However, it is not yet known how the 3D structure of a normal or diseased tissue is 
formed and influenced by the one-dimensional sequence of nucleic acids5, 6.  The 
following examples demonstrate the need to detect and learn more about how nucleic 










 Are there DNA mutations within a subregion of a prostate tumor8? 
 How does microRNA expression vary across embryos9? 
 How does gene expression change as stem cells differentiate10? 
  
The answers to these and similar questions are elusive because it is difficult to detect 
nucleic acids as a function of position in biological tissues with current techniques.  
Current techniques for mapping or visualizing nucleic acids across tissues are 
constrained by issues with assay sensitivity, reproducibility, cost, or complexity.  Part 
of the problem is that the majority of mammalian mRNAs (about 95%) are in low 
abundance (less than 15 copies per cell)11, 12.  It is difficult to measure low copy 
number mRNAs with cellular-resolution techniques, such as in-situ hybridization 
(ISH)13-17.  Alternatively, the polymerase chain reaction (PCR) is used to amplify rare 
mRNAs to improve detection13, 17, but laborious techniques6, 18 are required to 
preserve spatial resolution at the scale of even a few millimeters.   
 
Therefore, the focus of this thesis is on the development of a new method for 
detecting nucleic acids across tissue samples by dividing a tissue into subregions, 
purifying nucleic acids from each tissue subregion, amplifying target nucleic acids 
within the tissue subregions using PCR, and detecting the targets using fluorescent 
labels.  This new method for mapping nucleic acids across tissue samples is therefore 




consistent, widely-applicable, and not prohibitively expensive or time-consuming) 
compared to existing techniques.  A more detailed description of existing techniques, 
their advantages, their limitations, and comparisons among them are provided in 
section 1.3. 
 
The aims are described in section 1.4.  Initially, 2D-PCR was developed and tested at 
the resolution of a few millimeters for detecting DNA across a frozen tissue section as 
a proof of concept, as presented in Chapter 2.  Next, the method was improved to 
perform the more challenging task of detecting and quantifying messenger RNA from 
frozen tissue sections, as presented in Chapter 3.  Finally, the method was developed 
further to quantify up to 24 messenger RNAs in archival formalin-fixed tissue 
samples, as presented in Chapter 4.  Many intellectual contributions were made to 
develop this method, as described in Chapter 6 and Chapter 7, 
 
2D-PCR will serve two purposes, as discussed in Chapter 5.  First, it will allow for 
biological research to identify the function of nucleic acids with respect to their 
locations in tissue.  Second, it can translate from a research setting to a clinical setting 
for analysis of solid tissues.  In the long-term, 2D-PCR could be used to inform 
medical diagnosis, prognosis, and treatment decisions, provided that spatial nucleic 






For the reader who is not familiar with the basic principles and methods in this thesis, 
a background is provided in this section.  This section provides basic knowledge 
about nucleic acids, why they are important, and how they change.  Common 
techniques used by researchers in the field are presented, including tissue storage, 
extraction of nucleic acids from tissues, and detection or quantification of nucleic 
acids by PCR.  Each background section also lists any assumptions or special 
terminology used in the thesis. 
1.2.1 Nucleic acids 
1.2.1.1 What are nucleic acids? 
Nucleic acids are biologically evolved macromolecules containing unique sequence 
information in a variety of lengths.  The reader is assumed to be familiar with the 
basic chemical structure of nucleic acids, including ATGC base pairing, molecular 
size, sense, double versus single-strandedness, and differences between RNA and 
DNA.  Some of the important features of nucleic acids are highlighted as follows. 
 
• Nucleic acids have a negatively charged backbone under most pH conditions. 
• RNA contains the bases adenine (A), uracil (U), guanine (G), and cytosine (C) 
while DNA contains A,G,C, and thymine (T) bases. 
• Nucleotides in two nucleic acids strands hybridize by strong hydrogen 




• RNA has one more hydroxyl group than DNA, which allows enzymes to 
distinguish between the two, but which also makes RNA less chemically 
stable, resulting in faster degradation.  
• RNA is normally single-stranded, while DNA is double-stranded. 
• Messenger RNA often contains long stretches of adenine sequences at the 3’ 
end of the molecule.  This is called a polyA tail. 
• DNA in a cell is tightly bound to proteins called histones to compress and 
structure the DNA into a chromosome.  
• Nucleic acid sequences are always created in a 5’ to 3’ direction by 
polymerases, therefore sequences are always presented and written using the 
same 5’ to 3’ orientation. 
• A human cell contains 6.6 pico-grams of DNA. 
 
1.2.1.2 Types of nucleic acids 
There are several classes of nucleic acids, with different functionalities, size ranges, 
and structures.   
 
• DNA codes for messenger RNA, contains 6.6 billion base pairs per genome, 
and is nearly identical in all the normal diploid cells of a human body.   
• Messenger RNA (mRNA) codes for proteins, is typically 500-10000 bases 
long, and varies greatly in copy number by cell type.  About 1-10% of total 




• MicroRNA (miR) regulates gene expression, is typically 20-25 bases long, 
and varies in copy number by cell type.   
 
1.2.1.3 Assumptions and use in the thesis 
For the thesis, the following assumptions are used. 
• No unintentional artifactual modifications to nucleic acids are expected 
beyond those due to storage or preservation methods.   
• While the methods described in the thesis may apply to studying 
mitochondrial, bacterial, fungal, plant, and artificial nucleic acids, they were 
not considered when developing the technique.   
 
For the thesis, the following conventions are used. 
• The words “nucleic acids” are used to refer to any mammalian DNA, 
messenger RNA, and microRNA sequences longer than 20 bases.     
• Total RNA includes messenger RNA, microRNA, ribosomal RNA, and 
transfer RNA.   
• The word gene generally refers to nucleic acid sequences that were 
characterized and curated in a database.  Mammalian DNA and mRNA 
sequences can be found using the NCBI database.  MicroRNA sequences can 
be found using the MirBase database2. 
1.2.2 Changes in nucleic acids 
In order to identify the functions and importance of a nucleic acid, a change needs to 




time, a change in space, or a developmental condition (i.e. diseased versus normal).  
A change is defined as any of the following listed.   
 
• DNA copy number gain or loss. 
• DNA base pair mutations. 
• DNA methylation – addition of a methyl group to base pairs. 
• mRNA or microRNA expression level changes.  
 
These changes can be significant or not, depending on the nucleic acid and state.  Not 
all of the listed genetic changes can be detected with ISH, as summarized in section 
1.3.6.  However, all of the listed changes can be detected using variations of PCR.  
PCR is described in the next section. 
1.2.3 Detecting genetic changes by the polymerase chain reaction (PCR) 
1.2.3.1 What is PCR? 
PCR was invented as an in-vitro method for amplifying DNA molecules19.  By using 
amplification, as little as one copy of DNA can be obtained at a high enough 
concentration in solution such that the amplified DNA can be seen with the naked eye 
using fluorescent staining.  PCR is most often used to amplify short target sequences 
(50 base pairs up to a few thousand base pairs).  Only specific molecules are 
amplified based on the design of the PCR reaction components, allowing for the 
specific and sensitive detection of almost any sequence from any biological entity.  
Due to the sensitivity and specificity of PCR, the technique was rapidly adopted in 






























































Figure 1 – PCR and quantitative PCR publications by year.  Data generated by performing a 
Pubmed search by year, in title or abstract, for the quoted phrase “polymerase chain reaction” 
or the phrase [qPCR or "quantitative PCR" or "real-time PCR"]. 
 
1.2.3.2 How does standard PCR work? 
In this section, the fundamentals of PCR are explained, standard PCR reaction 
components are explained, and terminology common to the field is provided.   
 
PCR works by exploiting the fact that single-stranded DNA sequences naturally 
hybridize by base-pairing, and that DNA polymerases copy a longer DNA sequence 
(template) that is hybridized to a smaller DNA sequence called a primer.  Three steps 
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Figure 2 – The polymerase chain reaction doubles the amount of DNA using the three steps of a 
PCR cycle.  In step 1), the double-stranded DNA is first heated to denature (separate) the two 
strands.  In step 2) primers are hybridized to the target DNA by lowering the reaction 
temperature.  In step 3) the primers are elongated in a 5’ to 3’ direction by DNA polymerase, 
copying the template DNA strand. 
 
1. Denaturation – A target double-stranded DNA sequence is first heated to 
separate the two complementary strands.  Typically, this occurs at a 
temperature of 95 °C and requires 5 to 15 seconds. 
2. Annealing – Two short DNA sequences added to the reaction mix called 
primers or oligonucleotides, typically 16-30 bases long, are hybridized to each 
target DNA strand specifically.  The annealing occurs in an aqueous buffer at 
a specific temperature.  The temperature is typically 55 ° C- 60 °C, and 
annealing usually takes 30 seconds. 
3. Elongation – DNA polymerase extends the primer, in a 5’ to 3’ direction, by 




bases can be incorporated per second.  The temperature range is typically 60 
°C - 72 °C for elongation, and elongation usually requires 30 seconds. 
 
The steps of denaturation, annealing, and elongation are called a PCR cycle.  Each 
PCR cycle in theory produces two identical copies of double-stranded DNA for each 
copy of double-stranded DNA in the reaction.  Although the ideal doubling would 
give a 100% PCR efficiency, in practice PCR efficiencies are typically 80%-90%20.  
The PCR steps are repeated as many times as necessary to be able to detect the target 
DNA with downstream techniques.  The repetition of PCR cycles is called 
thermocycling.  Typically, 20-40 PCR cycles are used.  After a certain number of 
cycles, the PCR reaction reaches a point at which the amplified DNA is no longer 
copied efficiently due to inhibition of the reaction, caused by binding of the 
polymerase to its amplification products.  Typically, no more than 40 PCR cycles are 
needed.  By the end of a PCR reaction, billions of amplified DNA molecules are 
present.  To verify a successful PCR, gel electrophoresis followed by fluorescent 
staining is used to validate a PCR product size. 
 
The PCR reaction mixture typically consists of only a few components.  The 
components are mixed before thermocycling.  The most basic PCR components for a 
typical reaction are listed in Table 1.  The reaction components are normally 
optimized and the buffers may need to be modified to enable the use of special 
polymerases.  A demonstration of optimizing reaction components was provided by 





Table 1 – The essential components, their functions, and typically ranges for a basic PCR 
reaction.  Abbreviations: picogram (pg), microgram (µg), nanomolar (nM), micromolar (µM), 
nanomoles (nmol). 
Component Low Range High Range Function
DNA Template 5 pg 1 µg Target to detect
Primer 1 50 nM 1 µM Targets first DNA strand
Primer 2 50 nM 1 µM Targets second DNA strand
Buffer - Tris pH 8.3 5 mM 20 mM Stabilizes reaction mixture
Buffer - KCl 25 mM 100 mM Increases reaction efficiency
Magnesium Chloride 1.5 mM 6 mM Co-factor for polymerase enzyme
dNTPs 50 µM 500 µM Single base-pairs to make new template
DNA Polymerase* 0.02 Unit/ µL 0.2 Unit/ µL Elongates DNA at primers 1 and 2
* Manufactuers test polymerase activity and defined units to account for variations between lots.
One unit of enzyme incorporates 10 nmol of nucleotides at 74 ºC in 30 minutes  
 
The common terminology of the PCR field is provided in the next list. 
• Thermocycling or PCR cycling – The physical process of heating a sample 
through a range of temperatures many times to control the number of rounds 
of DNA amplification. 
• PCR primers or oligonucleotides – Sequences of single-stranded DNA, 
usually 16-30 bases long. 
• Template – The purified sample containing many nucleic acids. 
• Target – A specific nucleic acid sequence within a template.  The PCR 
primers are designed to anneal to the target. 
• dNTPS or deoxynucleotide triphosphates – The four individual building 
blocks needed to copy a DNA strand, including A, T, G, and C. 
• PCR amplicons – The amplified target products of PCR.   





• Primer dimers – Short PCR products created during PCR that are formed by 
mispriming of PCR primers to themselves23. 
• PCR efficiency – Actual rate of doubling per PCR cycle, in percent. 
 
PCR has been widely adapted to detect the full range of nucleic acid changes, 
including DNA methylation, copy number changes, microRNA expression levels, and 
mRNA expression levels.  This wide applicability allows PCR to detect molecules 
that many other methods cannot, as described in section 1.3.   Furthermore, PCR has 
been modified over the years by providing more advanced detection schemes as 
described in the next section.   
 
1.2.3.3 Advanced PCR 
Due to the robustness of the standard PCR reaction, many advanced modifications 
have been adopted.  This section highlights the different kinds of PCR that are 
relevant to the thesis. 
 
Quantitative real-time PCR determines the relative or exact amount of template in a 
PCR reaction.  Quantitative real-time PCR, or qPCR, works by measuring the 
intensity of fluorophores at the end of every PCR cycle, as shown in Figure 3.  The 
fluorophores increase in brightness proportionate to the buildup of DNA in a reaction 
tube.  As the fluorescent signal increases, it is possible to produce a plot of 
fluorescence versus PCR cycle.  This plot can be used to determine how much 




fluorescence to surpass a background threshold level (Cts).  By contrast, traditional 
PCR only looks at the end-products.  Because quantitative PCR is widely applicable, 
it has been rapidly adopted, as shown in Figure 1.   
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Figure 3 – The quantitative real-time polymerase chain reaction (qPCR) detects the amount of 
template by monitoring fluorescence, allowing for the quantification of starting template.   The 
qPCR reaction is based on a standard PCR reaction.  However, a molecular probe (TaqMan 
probe) is added to the reaction mix.  Upon elongation, the primer hydrolyses and releases 
fluorescent molecules into the reaction mixture.  The fluorescence is measured at the end of each 
PCR cycle.  The fluorescence intensity is presented as a graph that can be used to determine the 
amount of starting template relative to another qPCR reaction. 
 
There are two forms of qPCR.  The first form uses a dye that generally increases 
fluorescence proportionate to the amount of double-stranded DNA in a sample24.  
These dyes include ethidium bromide, SYBR Green I, or EvaGreen.  Since the dye 
detects all double stranded DNA, the amount of initial double stranded template in a 
reaction cannot be too concentrated, and the reaction is known for detecting false-
positives due to primer-dimer accumulation23.  It is therefore best suited for solutions 






The second form of qPCR uses molecular probe (also known as hydrolysis probe or 
TaqMan probe) chemistry, as depicted in Figure 3.  The probe is an oligonucleotide 
with a fluorescent molecule bound to the 5’ backbone of DNA and a quencher 
molecule bound to the 3’ backbone of DNA.  Because the quencher and probe are 
within 10 nanometers of each other, the fluorescence intensity of the fluorophores is 
reduced.  This fluorescence principle is called Förster resonance energy transfer25.  
Since the probe has a 3’ quencher, DNA polymerase will not recognize it as a priming 
site.  Instead, a primer upstream from the probe is used as a priming site.  As the 
polymerase elongates the parent strand, the polymerase will hydrolyze the probe, 
separating and releasing the fluorophores and quencher into solution.  Because the 
fluorophore and quencher are far apart, a fluorescent signal increase can be measured 
at the end of every PCR cycle, provided that the fluorescence is above the 
instrument’s measurement sensitivity.  Because the probe includes a third primer 
sequence, it adds enough specificity to a PCR reaction to virtually eliminate false 
positives.  As a result, it eliminates the need for gel electrophoresis.  However, 
molecular probes are more expensive than qPCR dyes.  Several references containing 
additional information on qPCR efficiency and qPCR equations are provided20, 26-29. 
 
Reverse-transcriptase PCR, another advanced form of PCR, enables the detection of 
RNA molecules.  RNA cannot be amplified by a standard PCR reaction because the 
DNA polymerase only recognizes DNA templates.  Therefore, RNA templates are 




transcriptase (RT) enzyme.  The RT enzyme converts RNA into cDNA using a 
primer, and RT enzyme elongates the primer by copying the RNA.  The primer is 
typically an oligo-dT or random oligo (6-10 random bases) to prime all possible 
mRNA sites.  RT reactions are normally prepared using RT enzymes and buffer in a 
reaction volume in a first tube.  Then, the cDNA is diluted into PCR buffer containing 
DNA polymerase in a second tube so that the RT buffer doesn’t inhibit PCR.  A 
typical two-step procedure dilutes an RNA template 10-15 times, reducing the 
amount of template and sensitivity of the reaction30.  RT-qPCR refers to quantitative 
RT-PCR. 
 
One-step reverse-transcriptase PCR uses only one tube for both the RT step and PCR 
step.  However, while the two-step process can turn all RNA into cDNA, the one-step 
process must use primers that are specific to a few target mRNAs.  There is evidence 
that an optimized one-step RT-qPCR is more sensitive for low abundance targets30.  
 
Special considerations are needed when using PCR to amplify low copy number 
targets.  If the number of target molecules in a sample is less than 20,  it is not 
possible to dilute the purified template to quantify more than one gene.  This is 
because the stochastic nature of random sampling (called the Poisson effect) causes 
the variability of PCR to increase if the sample is diluted31.  Furthermore, the Poisson 
effect can be worsened with increasing PCR volume.  As a result, if the number of 




allowing for the quantification of just one mRNA.  To quantify the expression of 
more than one gene, multiple templates would need to be prepared.   
 
Multiplexed Tandem PCR is a technique for amplifying up to 92 nucleic acid targets 
in a single PCR reaction32-34, to detect multiple low-abundance targets (multiplexing).  
Tandem PCR allows multiple genes to be profiled from a sample by pre-amplifying 
many transcripts, so that all of these transcripts can be detected in a subsequent qPCR 
reaction.  Because the templates are concentrated during the tandem PCR, sensitivity 
is not lost, which would be the case if the template was diluted instead (Poisson 
effect).  To perform tandem PCR, a mixture of standard PCR primers is used to prime 
many targets.  The primers are diluted to 100 nM and the PCR anneal time is also 
increased to 4 minutes to prevent bias – the less efficient amplification of any one 
target over another. 
 
Methylation-specific PCR uses modifications of DNA before PCR to detect changes 
in DNA methylation patterns35, 36.  This procedure is beyond the scope of this thesis 
but is included to demonstrate the wide applicability of PCR for detecting the 
different changes to nucleic acids. 
 
Fluidigm PCR assay – is a technique for improving the throughput of qPCR.  The 
highest capacity that a traditional qPCR machines provides is 384 sample wells, 
allowing for the study of about a dozen genes in a few dozen samples.  However, as 




increases by a squared factor.  For example, to study 96 genes and 96 samples would 
require at least 27,648 pipetting steps, 24 384-well plates, weeks of qPCR run time, 
and thousands of dollars of reagents.  The Fluidigm approach solves these problems 
by using a microfluidic system to reduce the number of pipetting steps, such that the 
number of pipetting steps scales linearly with the number of sample wells.  It also 
increases throughput by performing qPCR in up to 9216 miniaturized wells per 
experiment.  For example, to study 96 genes and 96 samples would only require 192 
pipetting steps.  Each sample or primer/probe set is provided to a Fluidigm chip, 
which uses microfluidic channels and pressure to mix each primer and each probe set 
into a miniaturized PCR well.  However, the Fluidigm system dilutes templates so 
much that it requires a pre-amplification step (tandem PCR).   
 
1.2.4 Typical methods of tissue sample preservation and storage 
1.2.4.1 Need for sample preservation 
Solid biological tissue samples are obtained from a living or recently deceased 
organism.  Removing a tissue cuts off its blood supply and starts a process called 
ischemia.  Ischemia causes cellular processes to change due to loss of oxygen and 
other essential cell growth chemicals in the blood.  Therefore the state of nucleic 
acids in the ischemic tissue partially reflects dying cells rather than a snapshot of the 
nucleic acids in living tissue.   
 
For molecular analysis, it is very important to preserve samples quickly because gene 




important to preserve samples for storage because it takes many weeks or months to 
perform a nucleic acid study.  It is even common to archive large numbers of tissue 
samples for future research projects on the scale of years.  A survey of best practices 
for biospecimen handling and a list of existing human tissue/biospecimen repositories 
was compiled by RAND Science and Technology37.   
 
1.2.4.2 Types of sample preservation 
Sample preservation most often includes freezing tissues or crosslinking tissues with 
formalin.  Frozen samples are kept at -80 °C for storage, while formalin tissues are 
stored at room temperature.  Less often, fresh tissues are preserved in a solution of 
ammonium nitrate, fixed with ethanol38, or used immediately without preservation.  
Solid tissue samples may be as small as one centimeter long and 1 millimeter in 
diameter (cylindrical biopsies), or as large as whole organs and even entire animals.  
Common sample preservation techniques are described below.   
 
1.2.4.3 Formalin fixation 
Formalin fixation uses formaldehyde to crosslink tissue proteins together by covalent 
bonds39.  Typically, a solid tissue is placed directly in a solution of formaldehyde for 
several hours or days.  To prevent fixation differences across the tissue sample, 
formalin needs to penetrate the tissue quickly.  Tissues are usually cut so that one 
dimension is small (< 5 millimeters) to allow faster penetration of formalin.  After 
fixation, the tissues are dehydrated to remove water for long-term storage.  




increasing levels of ethanol, followed by 100% ethanol, and followed by 100% 
xylene.  The tissue is then placed in paraffin wax to “embed” the tissue by filling 
voids.  The embedding also allows the tissue to be sectioned for light microscopy and 
prevents water from entering the sample during long-term storage. 
 
It is very important to note that formalin fixation is the predominant method of 
sample preservation, as evidenced by the RAND report37.  For example, the human 
cooperative tissue network supplies 5-10 times as many formalin fixed samples than 
other sample types.  There are four reasons for the wide-spread use of formalin.  First, 
the formalin fixation method was available before freezing techniques.  Decades 
before samples were frozen, pathologists studied cells under a light microscope and 
trained themselves to recognize morphological features of tissue with respect to 
artifacts caused by formalin fixation40.  Second, the formalin fixation method does not 
require a -80 °C freezer to store samples, saving the costs and space of freezer 
equipment and maintenance.  Third, the formalin fixation can inactivate harmful 
pathogens and viruses in a biological sample, and likewise prevents any external 
bacteria from entering the sample.  Fourth, the formalin-fixation, followed by paraffin 
embedding (FFPE), can increase the mechanical strength of tissue, allowing the 
layout of a sample to be preserved.  A good example is lung tissue, which is hollow 
and could not be sectioned unless filled. 
 
There are also disadvantages to formalin fixation.  It is common for labs or hospitals 




sample that is left too long in formalin will over-crosslink, resulting in poor quality 
RNA41.  However it is becoming more common for labs to use carefully controlled 
protocols to preserve tissues with considerations for RNA quality37, 41.  A second 
major disadvantage is that for unknown reasons, sample molecular quality degrades 
over time.   Possible causes of molecular degradation include oxidation, hydrolysis, 
cross-linking, and other chemical modifications.  A third disadvantage is that the slow 
speed of fixation hinders decision-making. A quick decision based on tissue 
morphology is often needed during the middle of medical surgery.  Therefore, 
intraoperative histology is usually obtained by staining snap-frozen tissues or cells 
smeared from fresh tissue directly onto a slide.  The slow speed of fixation can also 
cause autolysis or delayed protein immobilization in the center of a large sample, 
such as a brain. 
 
1.2.4.4 Other forms of sample preservation 
There are other ways to preserve tissue samples.  After formalin fixation, the most 
common preservation method is freezing.  Tissues can be frozen on dry ice or in 
liquid nitrogen to rapidly preserve the tissue and the molecules inside.  Frozen 
samples provide much longer (higher molecular weight) nucleic acid sequences than 
formalin fixed samples and may prevent chemical modifications of nucleic acids42.  
However there are many disadvantages to freezing.  First, the samples require great 
care because once frozen, thawing will cause nucleic acid degradation43; freezing 
followed by thawing ruptures the cell sub-compartments and causes the contents to 




Ribonucleases (RNases) will degrade RNA and deoxyribonucleases (DNases) will 
degrade DNA.  Second, frozen samples require expensive and large freezers to store 
the samples.  Third, any viruses or pathogens in the sample may still be active once 
the tissue is thawed. 
 
Other tissue fixation methods include RNAlater, which is a solution of ammonium 
nitrate that preserves molecular quality.  Ethanol fixation can also be used to 
dehydrate a sample, aggregate proteins, and preserve molecular quality38.  Fresh 
tissue can also be used, but special tools are required to cut fresh tissues into thin 
sections.   
 
Molecular quality due to preservation 
The quality of nucleic acids, particularly RNA from tissue samples, varies based on 
preservation methods and storage time.  Quality can be defined as the average length 
of nucleic acids recovered from a sample, but also needs to take into account the 
possibility of chemical modifications.  Fresh samples are known to have the highest 
quality nucleic acids, whereas long term formalin fixed samples are known to have 
the poorest sample quality33, 44.   The quality of nucleic acids from freshly-fixed 
samples and frozen samples is in between fresh and long-term formalin-fixed 
samples.  The impact of sample molecular quality due to preservation methods is an 





1.2.5 Typical methods for recovering nucleic acids  
Nucleic acids need to be extracted and isolated from tissues in order to be amplified 
by PCR.  The nucleic acids in a tissue are mixed with other molecules such as 
proteins, lipids, carbohydrates, and salts, all which can inhibit PCR.  Of critical 
importance, tissues also contain natural (endogenous) RNases and DNases that 
degrade nucleic acids.  Therefore the first step to recovering nucleic acids is to inhibit 
the action of RNases or DNases.  The next step is to break open the cells (lysis).  The 
last step is to purify the nucleic acids from the other cellular components.  Care is 
required to isolate nucleic acids intact from tissues for subsequent analysis.  This 
section describes three common ways to recover nucleic acids. 
 
1.2.5.1 GITC, phenol, chloroform, and isoamyl alcohol 
One of the most cited academic papers in history is by Chomczynski and Sacchi 
(50,000+ citations), which demonstrated a chemical mixture that lyses cells and 
maintains molecular quality in one step46.  This technique has been widely adopted 
because it could isolate total RNA from frozen samples faster (4 hours) than other 
methods available at the time.  Furthermore, the technique recovers high quality RNA 
from tissue samples rich in RNases, such as pancreas.   
 
The method works by first denaturing and inhibiting RNases using the chemical 
guanidinium isothiocyanate (GITC).  Surfactants and buffers are added to the GITC 
to help lyse cells.  Water-saturated phenol and a mixture of chloroform-isoamyl 




aqueous upper phase containing RNA, a middle liquid interphase containing DNA 
and proteins, and a pink lower organic phase containing proteins and lipids.  The 
aqueous phase is carefully removed without removing any interphase or lower phase 
components.  Alcohol is added to the aqueous phase, and the sample is cooled to -20 
°C for an hour to precipitate the RNA.   The sample is centrifuged to concentrate the 
RNA into a pellet, and the supernatant is removed.  The RNA is resuspended in 
ethanol several times to wash it, and is finally vacuum dried.  To isolate DNA using 
this method, the GITC is not included in the initial step. 
 
Although the technique was created in 1987, it is still popular because it isolates 
nucleic acids from large tissue samples effectively.  It also isolates small RNAs very 
effectively.  However it has major drawbacks.  First, the technique will not work for 
small tissue volumes because a sufficient weight of nucleic acids (nanograms to 
micrograms) is needed to create a concentrated RNA pellet.  Second, the 
centrifugation step requires careful handling and manual inspection to ensure that 
only the aqueous phase is removed. Otherwise organic solvents will be present in the 
purified sample that will inhibit PCR.  Third, the technique uses chemicals that are 
labeled as toxic.  Fourth, the technique requires special equipment, several tubes, and 
many reagents.   
 
1.2.5.2 Silica purification technology 
A technique using silica to bind and purify nucleic acids was optimized by Boom et al 




simplifies the centrifugation step, eliminates error from precipitating nucleic acids 
into a pellet, and eliminates the use of toxic chemicals like phenol.  The Boom 
technique uses GITC buffer to lyse cells in suspension.  Silica (glass) microbeads 
(diatoms) are then added to the lysed sample.  The silica captures nucleic acids in the 
presence of chaotropic salts like GITC due to several effects.  Primary effects include 
the increase of DNA mobility and dehydration in denaturing buffers, the absorption 
of water at the silica surface, and the reduction of negative silica surface potential in 
high ionic strength buffers49.  The silica is centrifuged, holding on to the nucleic acids 
while allowing other lysed cell constituents to wash away.  The nucleic acids are 
purified further by rinsing with ethanol, without removing (eluting) the nucleic acids 
from the glass.  Finally, water is added to the glass to elute the purified nucleic acids.  
Because the nucleic acids are bound to particles rather than floating free in solution, 
this technique is called solid-phase purification. 
 
The Boom method cut the sample preparation time from 4 hours to 1 hour.  It also 
eliminated the need to use phenol-chloroform, which is more hazardous than just 
using chaotropic salts.  The purification efficiency of the method (nucleic acids 
recovered vs input) is about 50%47.  This technique is still popular today and modern 
variations use a silica membrane in a spin-column in place of silica beads to improve 
handling by eliminating the chance of pipetting microbeads.   
 
However, the technique has the disadvantage that it was designed to lyse cells in 




to be homogenized first.  Most often, the tissues are mechanically ground, for 
example in a blender or using a mortar and pestle in liquid nitrogen.  If the tissue is 
not first homogenized, tissue fragments will not fully dissolve and will clog pipette 
tips and silica surfaces. 
 
The technique also selects for certain nucleic acids.  It typically isolates nucleic acids 
that are larger than 200 base pairs.  This means that semi-degraded RNA from 
formalin-fixed samples and naturally small RNA like microRNA cannot be efficiently 
purified.  The Boom technique also isolates DNA, which may interfere with RNA 
detection and may need to be degraded by a DNase treatment47.  Lastly, the fluid flow 
through the pores in a silica membrane can cause long DNA molecules to shear into 
smaller fragments. 
 
1.2.5.3 Magnetic beads 
Another advance in tissue lysis and nucleic acid purification was the introduction of 
magnetic beads with a nucleic acid binding surface50-52.  With the magnetic bead 
method, tissue is first ground into a frozen powder, or cells in suspension are used as 
with the Boom method.  The tissue is lysed in a lithium chloride buffer with 
surfactants.  Magnetic beads coated with oligo-dT molecules are added to the lysate 
to specifically hybridize to the polyA tails of mRNA.  The magnetic beads are 
concentrated using a magnet, which pulls mRNA away from other components in the 
lysis buffer.  The mRNA is purified using aqueous salt buffer washes.  The purified 




time down from one hour down to 15 minutes by eliminating the need for 
centrifugation. 
 
The original magnetic bead-based purification used oligo-dT molecules which is 
limiting.  Oligo-dT molecules do not capture DNA, small RNA, or total RNA.  They 
also introduce bias in that the mRNA molecules are only captured if they have polyA 
tails, and any breaks in the RNA molecule upstream from the polyA tail will not be 
purified.  Therefore, this technique is only good for working with high quality (fresh 
or frozen) tissue specimens.   
 
To address some of these deficiencies, the company DNA Research Innovations 
patented a magnetic bead-based surface using a “ChargeSwitch” material53.  The 
patent was awarded in 2005 and the technology was licensed to Invitrogen.  The 
ChargeSwitch material is similar to silica beads because they both capture or elute 
total nucleic acids by changing a single variable (pH or salt concentration of water).  
For ChargeSwitch beads, the pH is lowered below 4.5 to capture nucleic acids, while 
the pH is raised above 8.0 to elute nucleic acids.  Because the ChargeSwitch surface 
captures total nucleic acids and because the magnetic beads eliminate the need for 
centrifugation, the ChargeSwitch magnetic beads were used extensively for our 2D-
PCR protocol.  However, no literature characterizing ChargeSwitch magnetic beads 





1.2.5.4 Proteinase K  
Another method for lysing tissues to recover nucleic acids is the use of proteinase K.  
The proteinase K method uses a simple buffer to stabilize pH, and proteinase K, an 
enzyme that digests proteins in tissues to lyse cells.  Although proteinase K is a 
protein itself, it is resistant to the enzymatic denaturants and to the inhibitors SDS, 
urea, and EDTA54.  This makes proteinase K ideal for use in denaturing buffers.  
Once a sample is lysed with proteinase K, the released nucleic acids may be used 
directly by heat inactivating the proteinase K, but it is more common to mix the lysate 
with GITC and to purify with one of the previously discussed purification techniques. 
 
1.2.5.5 Special considerations for formalin fixed samples 
It should be noted that formalin fixed samples were not originally intended for 
preserving the molecular integrity of nucleic acids.  However, the recovery of nucleic 
acids from formalin fixed samples is increasing55, 56 because most solid tissues are 
formalin fixed.  Since the proteins are already crosslinked in these tissues, there is 
little concern about releasing endogenous RNases.  Instead the challenge is getting 
the nucleic acids out of the tissue.  For working with formalin fixed samples, 
proteinase K provides the highest yields of nucleic acids and is the predominant lysis 
method42, 44, 56, 57 
 
Another special consideration for formalin fixed samples is that the effects of fixation 




moisture are applied to a formalin fixed sample, the chemical crosslinks will be 
hydrolyzed.  This is approach is called antigen retrieval58, 59.   
 
1.2.6 A common lab workflow to study changes in nucleic acids  
A sample project workflow is provided in order to show how the methods presented 
in this section (sample fixation, nucleic acid purification, and qPCR) fit together.  
Typically, the experiment begins with the hypothesis that a change in nucleic acids 
confers a biological difference or diseased state.  In order to determine the difference, 
at least two nucleic acids are quantified from normal and non-normal (diseased) 
tissues.  At least one nucleic acid called a housekeeping gene is required.  The 
housekeeping gene is one that does not change between the diseased and normal 
states and can be used to account for differences in nucleic acid recovery between 
different samples.   
 
1. Obtain tissue (normal, non-normal) from surgery or biopsy. 
2. Preserve tissue (i.e. by freezing). 
3. Section tissues with a cryostat microtome. 
4. Scrape tissues into different sample tubes (i.e. tumor vs normal). 
5. Quickly lyse samples in denaturing buffer (i.e. GITC).  
6. Purify the nucleic acids of interest (i.e. RNA using a spin column). 
7. Quantify the desired target nucleic acids by qPCR (i.e. tumor promoter). 




9. Normalize the amount of target to housekeeping genes to account for and 
measure differences between two samples60-62. 
10. Determine the significance - is there a novel finding (i.e. t-test, p<.05). 
11. Validate findings using other methods (i.e. ISH, IHC, see section 1.3).  
1.2.7 Summary 
It should be noted that the methods described in this section apply to studying nucleic 
acids from large areas of tissue.  Most often gross regions of tissues are analyzed as a 
whole - on the scale of millimeters or centimeters.  However, tissues are made from 
dozens of cell types and have significant cellular heterogeneity, which may reduce the 
significance or utility of nucleic acid studies using mixed cell types63-65.  In the next 
section, methods intended for studying the layout of nucleic acids in a tissue sample 
are described. 
1.3 Current methods for localizing nucleic acids in tissue 
1.3.1 In-situ hybridization (ISH) 
ISH can localize specific nucleic acids at the cellular level.  By studying nucleic acids 
across a tissue sample cellular heterogeneity is preserved, tissue morphology is 
preserved, and even sub-cellular features can be examined.  As a result ISH has 
become a central tool in molecular biology for explaining fundamental processes16, 40.  




























































Figure 4 – In-situ hybridization (ISH) publications by year.  Data generated by performing a 
Pubmed search by year, in title or abstract, for the quoted phrase “in situ hybridization.” 
 
ISH works by hybridizing an artificially created oligonucleotide (probe) with either 
DNA or RNA in the cell.  Initially, ISH required the use of radioactive labeled 
probes, slowing its growth for almost 20 years until safer and more sensitive 
fluorescent and indirect labeling methods were created16.  Today the probe is labeled 
with either a direct reporter such as a fluorescent molecule, or an indirect reporter, 
such as biotin or digoxigenin, that is detected at a later stage.  A typical ISH involves 
many steps and days to complete.  An exemplary ISH protocol is summarized below 
based on the whole-mount mouse embryo staining technique by Correia and 





1. Day 1: 
a. Place tissue sample on slide. 
b. Formalin fix samples to lock biomolecules in place. 
c. Lightly treat cells with proteinase to make cells permeable. 
d. Hybridize digoxigenin-probe overnight. 
2. Day 2: 
a. Rinse and wash several times. 
b. Add blocking reagents to reduce non-specific binding. 
c. Hybridize digoxigenin antibody overnight. 
3. Day 3 (up to 5 days): 
a. Rinse and wash several times. 
b. Monitor color development under a microscope. 
c. Wait 30 minutes to 3 days. 
d. Rinse overnight to preserve color. 
 
There are hundreds of recipes like this one claiming to be the best recipe for a specific 
tissue.  Therefore a key limitation of ISH is that it needs to be re-optimized for every 
tissue type and fixation method.  It was shown to be difficult to reproduce some ISH 
protocols between labs due to cellular artifacts 67-69.   
 
A second key limitation is the low sensitivity of ISH.  ISH is most commonly 
reported to have a detection sensitivity of “10-20 copies” of target mRNA per cell13, 




great to detect the target.  Furthermore, whereas a long probe can be made to detect 
single DNA molecules, several smaller probes are used to detect many more mRNA 
molecules because mRNA is naturally shorter and degraded.  Because most 
mammalian mRNA is present in low copy numbers (less than 15 per cell) and 
because low copy transcripts are hard to detect, relatively few studies using ISH focus 
on gene expression73. 
 
A third limitation is that ISH cannot easily detect changes to small nucleic acid 
sequences.  The proteinase K step that makes tissue permeable and the wash 
procedures will rinse away target nucleic acids.  Just as easily as probe can enter the 
cells, so can the small RNA diffuse out of the cell.  This issue has been recently 
addressed with some success74, but the protocol takes 1 week.  Similarly, it is not easy 
to detect DNA methylation (a single base pair modification) with ISH, although one 
publication has recently addressed this challenge75, it is too early to tell if the 
technique works well. 
 
A fourth limitation is that ISH is most effectively used as an on/off detection tool76.  
It is not normally possible to quantify the amount of target.   
 
A fifth limitation is that freshly-fixed samples need to be used in order to detect low 
abundance mRNA transcripts.  During a freeze-thaw or storage with formalin 




abundance transcripts therefore focus on cell culture or mouse models so that fresh 
tissue is available. 
 
A sixth limitation is that usually only one target is optimized for study per tissue 
section.  This uses more tissue sections than if multiple targets could be detected 
(multiplexed) from a single tissue section.  In principle, ISH can use combinations of 
up to 6 colors with 21 target probes to detect different regions of chromosomes76, but 
it is normally only multiplexed for 2 or 3 targets for mRNA77, 78. 
 
As a result of these critical limitations (summarized in Table 2), ISH is mainly used in 
clinical medicine to identify viruses79 or to diagnose cancers using a few highly-
abundant mRNAs in cancer when diagnosis by protein-staining methods (see 1.3.5) 
fail79-81.  ISH is primarily still a research tool, and its use or significance seems to 
have plateaued, as shown in Figure 4. 
 
Table 2 – Benefits and limitations of in-situ hybridization (ISH). 
Resolution Sensitivity Time Complexity Reproducibility
<5 µM Low Days High Good
Samples Targets Multiplexing Quantitation Minimum Target
Fresh-Fixed DNA, mRNA 1-3 Targets No 20 copy/cell  
 
1.3.2 In-situ PCR (ISP) 
In order to circumvent the critical limitation of ISH sensitivity, in-situ PCR (ISP) was 
developed in the early 1990s82.  The principle behind ISP is to amplify targets in 




amplification increases the number of targets and increases specificity due to the use 
of two primer sequences.  The use of ISP increases the number of targets available for 
ISH by about 50 times72, 82. 
 
The potential of ISP rapidly popularized the technique, but it soon became clear that 
ISP is not a reliable14, 68, 71, 72, 83, 84.  It turns out that the tissue environment is so 
complex that results are unreliable and irreproducible.  ISP is therefore not in 
widespread use, as illustrated by the number of publications on ISP versus time, 
shown in Figure 5.  Furthermore, just like ISH, quantification using ISP is “extremely 
difficult” as reported by Komminoth72.  ISP, like ISH, therefore appears to be best 
suited for detecting viruses85.  A summary of the benefits and limitations of ISP are 
provided in Table 3. 
 
Table 3 – Benefits and limitations of in-situ PCR (ISP). 
Resolution Sensitivity Time Complexity Reproducibility
<5 µM Low Days High Poor
Samples Targets Multiplexing Quantitation Minimum Target















































































































Figure 5 – In-situ PCR publications by year.  Data generated by performing a Pubmed search by 
year, in title or abstract, for the phrase [PCR in situ hybridization or "in situ PCR"]. 
 
1.3.3 Laser microdissection & PCR 
Laser capture microdissection (LCM) was developed by Emmert-Buck65 in 1996 to 
address the need for a more sensitive and widely-applicable technique to study 
nucleic acids from specific cells.  With LCM, a user places an 8 millimeter 
thermoplastic film (LCM cap) over a dried tissue sample.  The user then directs a 
laser to melt the film over a homogenous group of cells from the heterogeneous 
tissue.  Each laser shot takes about one second and covers a small group of cells, 
therefore many laser shots are needed to collect enough sample for analysis, typically 
averaging 10,000 laser shots per sample.  Removing the film pulls off the cells of 
interest.  The cells on the film are then lysed using standard GITC methods, and 




acids are purified in solution, they can be used with most available techniques such as 
qPCR, microarrays, whole-genome amplification, sequencing, etc.  However, by far 
the most common analysis method is qPCR because it is quantitative and because it 
makes the most use of the small amount of recovered sample.   
 
The LCM technique does not directly preserve the spatial resolution of nucleic acids.  
In fact, all of the cells captured on an LCM cap are mixed and analyzed together.  The 
purpose of LCM is to enrich for specific cell types (i.e. stromal tumor cells) from the 
bulk of the tissue, providing enough sample that low abundance mRNAs can be 
detected by qPCR.  In order to preserve the 2D layout of a sample using LCM, 
multiple caps must be collected from a variety of locations across tissue.  Days to 
weeks are needed to perform the LCM and additional days to weeks are needed to 
perform the purification and nucleic acid analysis on the large number of specimens8.  
The sensitivity of LCM followed by the quantification of gene expression by qPCR 
has made LCM a widely accepted technique, as evidenced by its publication history 
(Figure 6).  In addition, because LCM uses downstream molecular techniques, 
changes in DNA methylation and microRNA expression can be detected - these 
nucleic acids cannot be detected easily with ISH or ISP. 
 
However, LCM has several limitations.  First, many cells are needed to provide 
sufficient nucleic acids for analysis.  Typically, tens of thousands of individual laser 




fresh cells contain about 50 ng of RNA or DNA template.  This process is requires 
continuous operator input and may also be subject to user bias.   
 
A second limitation is the type of sample that can be used.  In order to adhere the 
melted polymer to the cells, the tissue must be dehydrated.  Most of the samples are 
frozen sections that are dehydrated in xylene.  The dehydrated tissue also needs to be 
processed within 30 minutes to prevent the re-activation of RNases by moisture in the 
air.  It is not common to use FFPE samples for LCM because even more laser shots 
are needed to make up for degradation of RNA in the sample. 
 
A third limitation is that only a small percentage of the whole tissue section can be 
examined in a reasonable time.  To obtain a more global view, it is desirable to obtain 
data from a significantly larger percentage of a tissue section8.   
 
A fourth limitation is that collecting a small amount of tissue causes nucleic acid 
purification efficiency to drop when using silica spin-columns87, 88.  Papers have been 
published showing the use of LCM to capture and study one cell, however special 
cellulose columns and nucleic acid amplification strategies are required to work with 
the limited material89.  While it is not common to work with single cells, these studies 
demonstrate the wide applicability of providing purified template, allowing the 





In summary, LCM solved the majority of problems with ISH in that it purifies the 
nucleic acids, allowing robust downstream detection methods to be used.  However, 
the critical limitation of LCM is the cost of labor and time to isolate, purify, and 
analyze many samples across a single section.  A summary of the benefits and 
limitations of LCM are provided in Table 4. 
 
Table 4 – Benefits and limitations of laser capture microdissection + PCR (LCM). 
Resolution Sensitivity Time Complexity Reproducibility
>10 µM High Days Medium High
Samples Targets Multiplexing Quantitation Minimum Target
Frozen Unlimited Unlimited Yes 5-50 ng  
 
 











































































































Figure 6 – Laser capture microdissection (LCM) publications by year.  Data generated by 
performing a Pubmed search by year, in title or abstract, for the phrase [laser microdissection or 





1.3.4 Macrodissection or voxelation & PCR 
The other alternative to laser capture microdissection is to manually dissect gross 
regions of tissue to preserve spatial heterogeneity, albeit on the scale of millimeters to 
centimeters.  To perform a macrodissection, subregions of tissue (i.e. tumor vs 
normal) are scraped into a tube without any regard to sample heterogeneity within the 
scrape.  Alternatively, a garlic-slicer like device can be used to cut the tissue into 1 
mm x 1 mm x 2 mm rectangles called voxels6, 18.  Dissected samples are lysed 
individually, and the nucleic acids are purified from the lysates and analyzed by 
methods such as PCR or microarray.  Like LCM, changes in DNA methylation and 
microRNA expression can be detected after macrodissection because the nucleic 
acids are first purified. 
 
While macrodissection and voxelation may appear crude, studies have obtained 
useful information with macrodissection that could not have been obtained with other 
techniques.  This is particularly true for mapping gene expression in the brain or for 
tumor research studies7, 90.  For example, sufficient sample is obtained from brain 
voxelation to perform microarray analysis directly.  If smaller samples were used, a 
transcriptome amplification step would be required, adding bias to the results. 
 
In fact, a macrodissection-based method made it into the clinic for diagnostic and 
prognostic purposes, and it is called the oncotype DX test91.  In the procedure of this 
diagnostic test, formalin-fixed tissue sections are made from resected breast tumors, 




50% of the sample contains tumor cells.  It is possible to use such a heterogeneous 
sample because the signal from non-tumor cells in a sample do not overwhelm the 
signal from tumor cells, because tumor cells provide more RNA92.  Subsequently, six 
macrodissected tissue sections are lysed, RNA is purified, RNA is amplified by 
tandem PCR, and pre-amplified targets are quantified by qPCR to determine the 
expression of 21 genes.  16 of the genes are specific to cancer and are normalized to 
the average expression of five housekeeping genes.  If other techniques were used, 
such as microdissection, the sample analysis would have taken too long or there 
would not have been enough sample for a direct analysis.  Therefore, despite the 
millimeter-scale resolution, macrodissection is useful and versatile. 
 
There are only two major limitations with macrodissection.  The first is the obvious 
lack of spatial resolution below about one millimeter.  Macrodissection is 
fundamentally limited by the ability of an individual to scrape subregions of tissue by 
hand.   
 
The second limitation of macrodissection is the bottleneck caused by having to purify 
and analyze dozens or hundreds of nucleic acid samples in parallel87, 93, 94.  Typically, 
each macrodissected sample is placed into a tube for lysis.  Each sample is then 
placed into another tube for purification, another for recovery, and yet another for 
qPCR.  If hundreds of samples are processed this way, the technique becomes 





It is difficult to estimate how many studies scrape large areas of tissue.  However, one 
can estimate that the vast majority of studies using PCR, qPCR, and microarray 
detection also use non-cellular resolution techniques like macrodissection.  There 
were only 320 publications LCM in 2009, compared to 22,000 publications on PCR, 
qPCR, or microarray analysis (Figure 7).  Although many of the microarray or PCR 
studies may use uniform samples such as cells grown in culture, it is likely that 
thousands of studies each year use macrodissection methods on tissue sections.  The 
main reason for the popularity of macrodissection is the low complexity of the 
approach.  A summary of the benefits and limitations of macrodissection is provided 
in Table 5. 
 
Table 5 – Benefits and limitations of microdissection + PCR. 
Resolution Sensitivity Time Complexity Reproducibility
>1 mm High Hours-Days Low High
Samples Targets Multiplexing Quantitation Minimum Target
































































Figure 7 – LCM, PCR, qPCR, and microarray publications by year.  Data generated by 
performing a Pubmed search by year, in title or abstract as described previously for LCM, PCR 
and qPCR.  Microarray history was generated using the phrase [gene expression profiling or 
microarray not "cell microarray" not "tissue microarray"].  The difference in publications 
between LCM and these other techniques was 21,743 in year 2009.  These studies are presumed 
to use large tissue scrapes, cell culture, or other methods that do not provide spatially resolved 
information. 
 
1.3.5 Immunohistochemistry (IHC) 
Although it is intuitive to detect nucleic acids in tissues directly, many researchers 
will measure the indirect effects of nucleic acids on protein levels.  There is in fact a 
very strong direct correlation between mRNA expression and protein expression for 
some genes, but no correlation for others, as exemplified in Greenbaum’s study95.  
 
Immunohistochemistry (IHC) is a staining technique for detecting proteins in tissue 
samples.  Typically an antibody is hybridized to a target protein of interest.  The 




ISH, the weaknesses of IHC include sensitivity, reproducibility, and inability to 
quantify the amount of target in a sample80, 96.  As with the transcriptome (RNAs), the 
proteome is dominated by a few highly abundant proteins97.  IHC is most often used 
to provide a yes/no detection of a few medium and high abundance proteins for 
clinical diagnostic purposes81, 97-99.  A publication history of IHC is provided in 
Figure 8.   
























































Figure 8 – Immunohistochemistry IHC publications by year.  Data generated by performing a 
Pubmed search by year, in title or abstract, for the quoted phrase “immunohistochemistry.” 
1.3.6 Summary 
There are four major methods for localizing nucleic acids in tissues or cells.  Each 
method has major limitations and trade-offs, as summarized in Table 6.  ISH is 
capable of detecting highly abundant nucleic acids at the finest resolution.  ISP 
provides better sensitivity, but it was so difficult to reproduce results that ISP was 




tissue, is sensitive, reproducible, and allows for multiple downstream methods to be 
used – thus it is widely applicable.  However, LCM is still laborious, complex, and 
limited to high-quality samples.  Finally, macrodissection provides the maximum use 
of downstream methods and sample types, but it has the lowest spatial resolution.   
 
Table 6 – Benefits and limitations of four methods for localizing nucleic acids in tissues. 
Resolution Sensitivity Time Complexity Reproducibility
ISH <5 µM Low Days High Good
ISP <5 µM Low Days High Poor
LCM >10 µM High Days Medium High
Macrodissection >1 mm High Hours-Days Low High
Samples Targets Multiplexing Quantitation Minimum Target
ISH Fresh-Fixed DNA, mRNA 1-3 Targets No 20 copy/cell
ISP Fresh-Fixed DNA, mRNA 1 Target No 0.1-1 copy/cell
LCM Frozen Unlimited Unlimited Yes 5-50 ng
Macrodissection Any Unlimited Unlimited Yes 5-50 ng  
 
1.4 Aims  
1.4.1 A robust nucleic acid mapping method 
There are many trade offs between the benefits and limitations of current techniques 
for localizing nucleic acids in a tissue sample, as shown in Table 6.  There is therefore 
a need for a robust method – a technique that preserves spatial resolution but is 
sensitive, consistent, widely applicable, and not prohibitively expensive or time-
consuming.   
 
The focus of this thesis is the creation of a robust method for mapping nucleic acids 
in tissues.   Each of the desired aspects of a robust method are described further in 




goals.  Then, three aims achieved by the thesis towards establishing 2D-PCR as a 
useful technique are presented. 
 
1.4.1.1 Sensitivity 
A sensitive method is needed to detect low-abundance mRNAs, because the majority 
of mRNA is in a low-abundance class, defined as less than 15 copies per cell.  By 
comparing the existing techniques, it is clear that using solution-phase PCR as an end 
point detection method detects nucleic acids more sensitively that ISP or ISH.  The 
purification step allows cellular artifacts to be removed by purification, improving 
sensitivity.   
 
Furthermore, because the majority of clinical samples are formalin-fixed and may 
contain degraded nucleic acids, the copy number per cell is even lower.  There is 
therefore a need to detect RNA from formalin-fixed samples sensitively. 
Macrodissection appears to be the only method for studying these samples.  
Macrodissection can detect RNA from formalin-fixed samples because it pools 
hundreds or thousands of cells.  Therefore, some spatial resolution must be sacrificed 
to allow detection and quantification of targets.   
 
Finally, methods are needed for detecting small RNAs, because as these nucleic acids 
are being increasingly studied and implicated in protein regulation.  ISH and ISP do 
not offer reliable ways to study microRNA.  Therefore, purification methods are 






A consistent method is needed because techniques like ISP, ISH, and IHC have been 
unreliable, making it difficult to use them for clinic diagnostic purposes.  Because ISP 
attempted to amplify nucleic acids in cells, it turned out to be inconsistent.  A typical 
solution-phase PCR reaction amplifies molecules up to 1 billion times, but in-situ 
PCR reported only 50-fold amplification.  Furthermore, ISP and ISH require 
optimization and different protocols for each sample type.  Ideally, one protocol 
should be consistent enough that it works on a variety of tissues types and tissue 
preservation methods.  The only consistent methods appear to be LCM and 
macrodissection because they purify nucleic acids and use reliable downstream 
detection methods like qPCR. 
 
1.4.1.3 Widely applicable 
Another constraint of existing methods is that they are not applicable to a wide 
variety of tissue types, targets, and downstream detection methods.  There are several 
desirable traits that fit into this category, and these are listed below.  
 
Quantitative 
The technique needs to be quantitative.  So far, ISH and IHC are the only methods 
used in the clinic, but they are not quantitative.  They only work well on molecules 




used to provide unambiguous results.  The use of qPCR allows for quantitation of 
targets and may thereby improve clinical utility. 
 
Multiplexing 
ISP, ISH, and IHC generally look at one or two targets at a time.  Once the tissue is 
used, it is difficult to detect another target, so the sample must be discarded.  
However, there are over 20,000 genes, thus it is useful and often necessary to look at 
more that one gene at a time.  An example is the Oncotype DX test, which quantifies 
the expression of 21 genes per sample to make a diagnostic.  Therefore, multiplexing 
a few targets is inadequate for today’s needs.  The minimum amount of multiplexing 
that would be useful may be in the range of 20-100 targets.  This is currently possible 
using Tandem PCR. 
 
Target types 
The ideal technique would detect all of the possible genetic changes listed in section 
1.2.2.  As stated earlier, microRNA is not normally detected with ISH because the 
molecules are too small.  Furthermore, DNA methylation does not affect 
hybridization and it cannot be detected readily using ISH.    It is possible to detect and 
quantify all these genetic changes using variations of PCR. 
 
Tissue fixation methods 
The most common tissue preservation methods are formalin fixation and freezing.  




samples.  ISH and LCM methods can be used on other tissues types, but it is not 
common because different protocols are required.  For LCM, it is difficult to use 
archival formalin-fixed specimens, which require too many laser shots because the 
nucleic acid degradation.  Even for macrodissection methods, entirely different 
procedures are needed to isolate RNA and DNA from formalin fixed or frozen 
specimens.  Ideally one protocol would be used to work with a variety of different 
samples. 
 
Control of resolution 
Although it may be counter-intuitive, it is not always ideal to have the finest possible 
resolution.  The majority of archival clinical samples use formalin fixation.  The only 
way to validate a nucleic acid diagnostic today is by retrospectively analyzing 
archival patient samples and predicting patient survival.  In order to look at the 
potentially valuable but low-abundant, degraded RNAs from formalin samples, a 
method is needed that optimizes the level of resolution (size of tissue 
macrodissection).  If the macrodissection size is increased, then the recovery of low-
abundance RNA is also increased at the expense of resolution.  Currently, there is no 
method that can control the resolution of recovery while mapping nucleic acids across 
a sample. 
 
1.4.1.4 Not prohibitively-expensive or time-consuming 
The last requirement is a technique that is not prohibitively slow or costly.  In 




applicability, consistency, and sensitivity of these techniques.  However, the major 
limitation is that they are slow and expensive.  For example, the experiments in 
Chapter 4 showed that macrodissection of just 24 formalin-fixed samples, followed 
by nucleic acid purification using commercially available kits and analysis using 
qPCR took 2 days and cost nearly $1000.  For LCM, there is also the problem of user 
bias and the cost of labor, since a skilled operator is needed.  Finally, if a technique 
has diagnostic potential and is to be used during a medical surgery, it needs to have to 
potential to be used in under an hour, unlike the days needed for the existing methods.   
1.4.2 2D-PCR addresses all of these needs 
This thesis will show that 2D-PCR is an approach that solves all of these problems.  
2D-PCR works by first cutting a tissue into subregions by pressing a tissue section 
into a grid of wells, as shown in Figure 9.  Then, the steps of tissue lysis, RNA or 
DNA purification, amplification by PCR, and detection using fluorescent methods are  
 
Figure 9 – Schematic view of the 2D-PCR technique for spatial mapping of changes in genes and 
gene expression.   All of the genes from a tissue section are transferred to a grid of wells, a target 
nucleic acid is amplified by PCR under clean conditions within each well, and amplified gene 






performed.  This approach provides the sensitivity, wide applicability, and 
consistency of LCM and macrodissection but is faster and uses less reagents and 
consumables.  Therefore, 2D-PCR can be thought of as a high-throughout 
macrodissection technique that preserves the layout of a tissue. 
 
By dividing the sample into a grid format, 2D-PCR reduces the bottleneck of cutting 
subregions out of tissues sections and preparing nucleic acids87, 93, 94.  By maintaining 
the layout of tissue sample, time is saved because the relative positions of the nucleic 
acids are maintained.  By using a grid format and scaled-down volumes of reagents, 
the cost and speed of analysis is reduced by about an order of magnitude compared to 
existing methods.   
 
The other advantage of 2D-PCR is that in principle the size of grid wells can be 
scaled down, and the technique was designed with automation in mind.  It may be 
possible to scale down the technique to the resolution of glands (dozens of cells).  
Work towards miniaturization is described further in Chapter 2.  2D-PCR is the first 
method that controls the resolution of wells, accommodating samples that may have 
low-abundance targets and/or degraded or hard-to-recover nucleic acids. 
 
A summary of the advantages of 2D-PCR in comparison to existing methods is given 





Table 7 – Benefits and limitations of 2D-PCR and four methods for localizing nucleic acids in 
tissues. 
Resolution Sensitivity Time Complexity Reproducibility
ISH <5 µM Low Days High Good
ISP <5 µM Low Days High Poor
LCM >10 µM High Days Medium High
Macrodissection >1 mm High Hours-Days Low High
2D-PCR >1.6 mm High Hours Low High
Samples Targets Multiplexing Quantitation Minimum Target
ISH Fresh-Fixed DNA, mRNA 1-3 Targets No 20 copy/cell
ISP Fresh-Fixed DNA, mRNA 1 Target No 0.1-1 copy/cell
LCM Frozen Unlimited Unlimited Yes 5-50 ng
Macrodissection Any Unlimited Unlimited Yes 5-50 ng
2D-PCR Any Unlimited Unlimited Yes 1-5 ng  
 
The following 2D-PCR aims were achieved for this thesis.  The major difficulties 
overcome are summarized in section Chapter 6 and Chapter 7 and are specified as 
intellectual contributions 1-8. 
1.4.3 Aim 1 – Map DNA using 2D-PCR  
Aim 1 was to demonstrate the initial proof of concept of the 2D-PCR technique by 
mapping DNA from frozen tissue sections at a resolution of 1.6 mm.  First, a new 
process was developed for handling frozen tissue on adhesive films while preserving 
the layout of the tissue sample.  A process was then developed for transferring the 
tissue into a high-density multi-well plate, which also cuts the tissue into subregions 
1.6 mm in diameter (Contribution 1).  Throughout the process the sample layout was 
maintained by using a novel single-well procedure to directly extract, amplify, and 
detect the DNA, and the use of agarose plus sealing films to prevent the diffusion of 
DNA (Contribution 2).  A novel procedure was also developed for visualizing tissues 




glyceraldehyde 3-phosphate dehydrogenase (GAPDH) was created from a tissue 
section and shown to correlate with the spatial area of the sample.  The details of this 
aim, methods, and results were published in LabChip in 2009 and are presented as 
Chapter 2. 
 
1.4.4 Aim 2 – Map RNA using 2D-PCR  
Aim 2 was to demonstrate a second proof of concept of the 2D-PCR technique by 
performing the more challenging task of quantifying messenger RNA from frozen 
tissue specimens.  This was done using an industry standard 384-well PCR plate as 
the device.  First, a new process was developed for visualizing frozen tissue on 
adhesive film without affecting qPCR (Contribution 4).  A novel single-well 
procedure was then developed to extract, purify, amplify, and quantify the mRNA 
(Contribution 4).  Additionally, 2D maps were made for up to three specific mRNA 
targets in one tissue section.  Specifically, a map was created by detecting kidney, 
liver, or heart using mRNAs specific to these tissues.  The details of this aim were 
written as a manuscript draft to be submitted to Nucleic Acids Research and are 
presented in Chapter 3. 
 
1.4.5 Aim 3 – Mapping total RNA in FFPE tissue using 2D-PCR  
Aim 3 was to demonstrate the utility of 2D-PCR by mapping nucleic acids in real 
biological tissue samples.  However, it was not easy to find frozen human tissue 




tissues, but 2D-PCR was not originally developed for formalin-fixed tissues.  
Therefore the 2D-PCR method was modified again to allow the detection of total 
RNA (mRNA and microRNA) from formalin-fixed specimens.   
 
Several constraints were overcome to enable this study.  In order to test many tumor 
and normal samples, a custom tissue microarray (TMA) was created with 25 prostate 
tumor and 25 matched normal prostate samples from 25 different patients in total.  In 
order to transfer the TMA to the 2D-PCR device, a new adhesive film and procedure 
for sectioning and dewaxing TMAs onto the adhesive films was developed 
(Contribution 5).  In other to recover mRNA from the formalin fixed samples, a 
reverse-crosslinking step was introduced to the protocol (Contribution 6).  In order to 
improve the detection of low-abundance microRNA, a novel one-step microRNA 
amplification and detection procedure was developed that maintains the concentration 
of microRNA; current techniques dilute the microRNA using two-step procedures 
(Contribution 7).  In order to maximize the use of the precious tissue specimens, a 
procedure was optimized for pre-amplifying 28 mRNA targets in a single tissue 
section using tandem PCR.  Finally, to simplify the workflow for studying many 
genes across many samples, 24 of the mRNA samples were assayed by qPCR in 
duplicate against 42 prostate samples using Fluidigm, a miniaturized high-throughput 
qPCR system (Contribution 8).   
 
Combining these developments, the 2D-PCR approach for formalin fixed samples 




Furthermore, the technique validated 15 previously identified gene expression 
microarray profiles – the overexpression of ALCAM, AMACR, FOLH, and 
TACSTD1 mRNA in tumors, and the underexpression of ANG, CD69, GSTP1, 
H1F1A, JAK1, CD10, MUC1, SOD2, STAT5B, TIMP3, and VEGF mRNA in 
prostate tumors.  This result would not have been possible with other techniques in 
such a short period of time.  The results of this aim were written as a manuscript 





Chapter 2: DNA maps from frozen tissue 
 
In this chapter, the methods and results for mapping DNA from frozen tissue sections 
are presented, as described in aim 1.  This chapter presents these results as the 
entirety of a journal publication, currently in print100. 
 
Intellectual contributions:  I drafted the initial manuscript, performed all of the 
experiments, and developed the experimental methodology (see intellectual 
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A novel approach was developed for mapping the location of target DNA sequences 
in tissue sections.  The method combines a high-density, multi-well plate with an 
innovative single-tube procedure to directly extract, amplify, and detect the DNA in 
parallel while maintaining the two-dimensional (2D) architecture of the tissue.  A 2D 
map of the gene glyceraldehyde 3-phosphate dehydrogenase (GAPDH) was created 
from a tissue section and shown to correlate with the spatial area of the sample.  It is 
anticipated that this approach may be easily adapted to assess the status of multiple 
genes within tissue sections, yielding a molecular map that directly correlates with the 
histology of the sample.  This will provide investigators with a new tool to interrogate 
the molecular heterogeneity of tissue specimens.  
 
2.2 Introduction 
Variations in DNA status (mutation, epigenetic modification, insertions, deletions) by 
location within a tissue section are of interest for elucidating their roles in biology and 
as clinical markers for disease.  However, to study the molecular basis of normal and 
pathological conditions, many researchers identify genes of interest from tissue 
specimens by examining cell homogenates (all the cells in the sample mixed 
together).  Since tissue comprises a complex milieu of diverse cell populations that 
define the local microenvironments, combining the multiple cell populations into one 
measurement masks a tremendous amount of information.  Therefore, to achieve a 
more complete view, DNA variability within a tissue sample needs to be correlated 




the physical location within the tissue section, and/or histopathological features (for 
example, a specific disease lesion).  This is highlighted by the interest in techniques 
such as in-situ polymerase chain reaction (PCR), and more recently by the increasing 
use of laser capture microdissection (LCM).   
 
The majority of biological studies that extract, purify, and amplify genes or gene 
products from homogenized tissue to enable their detection utilize methods such as 
PCR 19, RT-PCR 101, qPCR 24, qRT-PCR 102, nano-liter qPCR 103, digital RT-PCR 104, 
DNA microarrays 3, 105, SAGE 106, oligonucleotide microchips 107, and OpenArrays 
108.  These techniques are capable of impressive sensitivity and high throughput 
capacity, while also being reliable and consistent among different labs.  However, due 
to the homogenization step, they do not preserve the original 2D histological 
correlation between the locations of different cell types and their underlying 
molecular information. 
 
Microdissection methods, including UV cutting 109, LCM 65, and its variants 
expression microdissection (xMD) 110 and immuno-LCM 111, were created 
specifically to work with histological tissue sections containing particular cell 
populations rather than homogenates.  These approaches preserve the histological 
information and can be used in conjunction with sensitive and reliable molecular 
biology methods, such as PCR, for the molecular analysis of the tissue.  For example, 
LCM has been used to isolate various cell populations of human prostate tissue to 




8.  LCM allows an operator to isolate selected clusters of particular cell populations 
under microscopic visualization.  A large number of like clusters are placed together 
into a standard 0.5 mL microcentrifuge tube and then studied with the same protocols 
used on tissue homogenates.  As a result of the information on cellular location, as 
well as its reliability, LCM is now a widely used technique.  However, creating a 
complete molecular profile across an entire tissue section is prohibitively time-
consuming with the current microdissection techniques.    
 
There are techniques for in-situ mapping of genes throughout a tissue section, 
including catalyzed reporter deposition 112, in-situ PCR 82, 113, rolling circle 
amplification 114, or branched DNA 115, 116.  These techniques aim to obtain the 
molecular profiles of the cells in their original milieu, preserving the correlation with 
histological and immunohistochemical 117 examination.  While this works well for 
some samples and targets, a widely accepted platform for 2D spatial molecular 
analysis has not yet emerged due to issues such as background autofluorescence 70 
and the need to re-optimize on a case-by-case basis 70.  To overcome these issues, it is 
typical to either amplify the target genes 82, 113, 114 or the reporter molecules binding to 
the target genes 70, 112, 115, 116 prior to visualization, and a few studies have even 
attempted multiple rounds of signal amplification 118, 119 to improve the signal to noise 
ratio.  Nevertheless, the in-situ techniques have not seen the same level of acceptance 





In this paper, we present the first lab-on-a-chip method to visualize target DNA 
across a tissue section.  This will allow, upon further development, the mapping of 
alterations in genes, such as loss of heterozygosity (LOH), single nucleotide 
polymorphism (SNP), changes in copy number, and methylation, and correlating 
these changes with the tissue histology.  This novel approach combines the strengths 
of three existing methods:  the amplification power of PCR, the ability to examine 
clusters of cells using LCM, and the ability to localize molecular targets across a 
tissue section by in-situ methods.  Our approach, which we call 2D-PCR, makes use 
of a miniature array of wells together with protocols that allow tissue lysis, DNA 
amplification, and target detection within the same well.  Proof-of-concept for this 
method was demonstrated via the creation of a 2D detection map, showing the 
presence/absence of the target DNA, on the millimeter scale, but resolution can be 
further improved to the micro-scale based on our preliminary findings.  In principle, 
this approach can be miniaturized to the level of a few cells per well, the same 
resolution as achieved with LCM but with more comprehensive study of the tissue 
section, thereby advancing studies of gene expression as a function of the type of cell 
and its position within a tissue.  We have also established this method of mapping 
DNA as a step towards the more challenging task of mapping mRNA and microRNA. 
 
2.3 DNA Mapping Methodology 
The 2D-PCR concept is illustrated in Figure 10.  A tissue is sectioned and transferred 
into a multi-well array device.  The DNA is then extracted from the tissue and 




genes while maintaining the reliability and specificity of PCR for detection.  The PCR 
products can be detected either within the wells or after products are transferred onto 
one or more detection membranes 120.   
 
 
Figure 10 – 2D-PCR is achieved by transferring a tissue section vertically into a multiwell array 
device, isolating tissue subregions.  The DNA is extracted and then amplified by the polymerase 
chain reaction.  A detection map is created by imaging the amplified DNA, for example using a 
DNA-intercalating dye.     
 
The steps to create the 2D map of DNA in tissue are illustrated schematically in 
Figure 11.  The multi-well device consists of a plate with an array of through-holes 
sealed on the bottom side to form the wells.  The wells are pre-filled with agarose, 
which immobilizes the chemical species to prevent cross-contamination between 
neighboring wells.  In step one, the tissue section is transferred onto the surface of the 
multi-well array (step 1A) and then pressed onto the surface (1B).  The contents of 
the well are dehydrated to enable the addition of lysis reagents (1C).  In step two, the 
tissue is lysed to release genomic DNA into solution.  Lysis reagents are added to the 
wells (2A), which are sealed and incubated at 65 °C (2B).  Sealing prevents 
evaporation of reagents during the incubation, and heating activates the enzyme in the 




dehydration at 95 °C (2C) to enable the subsequent addition of aqueous reagents.  In 
step three, the DNA is amplified.  PCR reagents are added (3A), and the device is re-
sealed and heat cycled (3B).  In step 4, the DNA is imaged.  After unsealing the 
device, an intercalating fluorophore is added and allowed to incubate (4A).  After 







Figure 11 – Experimental protocol used to demonstrate the 2D-PCR concept.  Tissue is 
transferred into wells, isolated, and lysed to extract the genomic DNA (represented by “x”s).  
PCR is performed to amplify the target DNA, and the targets are visualized with fluorescent dye 





2.4 Materials and Methods 
2.4.1 Device fabrication 
Devices were constructed from perforated aluminum (alloy 3003H14, Perforated 
Metals Plus) obtained in 30.5 x 30.5 cm2 sheets with 1.27 mm thickness.  The 
through-holes were used as wells/vials and had a 1.6 mm diameter and a 2.38 mm 
staggered center-to-center spacing.  The sheets were cut into 3 x 3 cm2 pieces for the 
experiments and cleaned with 100% ethanol.  These plates were used because they 
had the smallest commercially available hole size, near the size of a 1 mm pipette tip.  
They also had a flat surface and low aspect ratio holes to facilitate the transfer of 
tissue.   
 
Low melting point (LMP) agarose was added into the through-holes as an 
immobilizing medium because of its compatibility with a variety of enzymatic 
reactions 121, including DNA polymerase and reverse transcriptase.  LMP agarose 
(Lonza 50081) was mixed 2% by weight in 30 mL of water in a sterilized beaker and 
microwaved at 800 W for 60 seconds.  After the solution cooled to 50 °C, the cleaned 
aluminum plates were dipped into the molten agarose solution for a few seconds to 
fill the wells by capillary action.   
 
The back (burred) side of the plate was sealed with an 89 µm thick adhesive-backed 
fluoropolymer film (McMaster 5805T11) that was cut to 3 cm squares.  The sealing 
film was rinsed with ethanol, air dried, and placed in contact with the multi-well 




firmly on all corners to ensure sealing.  This sealing film remains permanently on the 
bottom side of the device.  A seal of 51 µm thick Kapton film (McMaster 2271K72) 
was also ethanol cleaned and then added to the smooth top side of the plate.  A large, 
flat, 2 pound weight was placed on top of the seal to create a smooth agarose surface 
for the tissue to be placed onto in the next step.   
 
2.4.2 Tissue sectioning and transfer 
Two types of tissue were used in these studies:  frozen tissue samples from a human 
prostate with benign hyperplasia and breast tissue with lobular carcinoma.  Both 
specimens were obtained at the National Institutes of Health as part of an IRB-
approved clinical protocol for molecular analysis.  Patient identifiers were removed 
prior to the study.  Tissue specimens were snap frozen and embedded in optimal 
cutting temperature (O.C.T.) compound embedding medium (Sakura Fine-Tek, 
Torrance, CA).  The tissue histology was evaluated by a pathologist (Rodriguez-
Canales) to confirm the presence of viable cells in the tissue blocks.  The blocks were 
then sectioned using a Leica CM1850UV cryostat.  Prostate tissue sections measured 
approximately 40 mm x 20 mm with 8 µm thickness, and breast tumor tissue sections 
measured approximately 5 mm x 15 mm with 12 µm thickness.   
 
For 2D gene mapping, the lobular breast carcinoma tissue block was stained so that it 
could be localized in the wells visually after transfer to compare against subsequent 
fluorescent detection of tissue DNA by 2D-PCR.  The tissue block was thawed at 




minutes.  It was immersed in 70% ethanol for 5 minutes and 15% ethanol for 15 
minutes, and then re-embedded in O.C.T. on dry ice for 10 minutes.   
 
Tissue sections were transferred to the multi-well device immediately after sectioning 
while still frozen to faithfully preserving the 2D geometry.  After removing the top 
surface Kapton sealing film, the device was placed top side down onto the tissue 
section.  Since the device was at room temperature, the tissue section and O.C.T. 
compound melted locally, adhering the tissue to the device, in a similar way that 
cryostat sections are typically adhered to glass slides for histological evaluation.  The 
tissue overlying each well was then pressed into the well by force:  the tissue was 
covered with a fresh Kapton sealing film and the plate/tissue/film was compressed at 
150 psi and heated to 95 °C for 5 minutes.  The device was then flipped and 
dehydrated as described below, so that the agarose would dry on top of the tissue to 
immobilize the DNA and thereby prevent cross-contamination between wells.   
 
2.4.3 Device heating and sealing 
To heat the wells for tissue transfer, cell lysis, and PCR while simultaneously 
preventing evaporation and cross-contamination of the wells due to internal vapor 
pressure, it was necessary to seal the wells of the device.  A standardized procedure 
was developed to repeatedly remove and reapply these seals.  Wells were reversibly 
sealed with a fresh 51 µm thick Kapton film during each step of the procedure.  This 
sealing film was rinsed with ethanol, air dried, and placed in contact with the multi-




square inch (psi) of force and heated using a customized compression-heating rig.  
The rig consisted of a steel frame supporting a weight scale, a PCR thermocycler with 
a flat heating surface, and a screw-type compression plate (see the Supplementary 
Materials for a figure).   
 
The multi-well plate device was placed on the flat surface of the thermocycler (Alpha 
Unit Flat Block/PTC-200 DNA Engine, BioRad) and 200 µL of mineral oil was 
applied to the heater surface to improve thermal conductivity.  The device was 
covered with a 1” thick Plexiglass block for thermal insulation and a 1” thick 
aluminum block for force distribution.  
 
After the heating procedure, the contents of the wells were solidified by cooling to 0 
°C for 10 minutes.  Solidifying the agarose, which entrapped the DNA and reagents, 
ensured that the contents from one well did not move into any adjacent wells and that 
no fluid adhered to the sealing film upon removing the seal.  After peeling off the 
film, the contents of the wells could be dehydrated by heating to 95 °C for 5 minutes.   
 
The reagents for the next procedure were added on top of the previously dehydrated 
well components.  To ensure that the reagents did not exceed the volume of the wells, 
the water in the reagents was allowed to evaporate at standard room conditions for 
approximately 10 minutes until the meniscus of the fluid inside the wells became 





We estimate that resulting variations in dilution are at most 5%, the same as that for 
commercial 96-well PCR plates.  It should also be noted that the evaporation of fluid 
would not affect the yes/no detection of DNA at the levels reported here.   
 
2.4.4 DNA amplification protocol 
To perform PCR amplification, PCR reagents were added to wells that had previously 
been dehydrated.  Standard PCR mastermix (Invitrogen 10572-014) was adjusted to 
0.1% weight/volume BSA (Fisher BP675-1), 60 U/mL Taq DNA polymerase 
(ABgene AB-0301a), and 2.75 mM MgCl2 (ABgene AB-0301a).  Primers were added 
to 200 nM for a GAPDH 167 bp genomic DNA target (5’catcatctctgccccctct and 
5’tgagtccttccacgatacca), unless otherwise specified.  The device was sealed with 
Kapton film, compressed, and then thermo-cycled.  PCR thermocycling was 
performed at 95 °C for 2 minutes followed by 35 cycles of 95, 56, and 72 °C for 10, 
10, and 15 seconds, respectively, followed by a final 72 °C step for 2 minutes and a 0 
°C step for 10 minutes. 
 
2.4.5 Visualization 
DNA intercalating dye was used to visualize the PCR amplification products.  The 
top sealing film was removed and 300 µL of a 10X dilution of SYBR Green-I dye 
(Fisher Scientific BMA50513) was added to the top surface of the device and allowed 
to diffuse into the agarose for 5 minutes.  SYBR Green-I is an intercalating dye that 




noise.  The device was placed on a blue light transilluminator (Clare Chemical 
DR45M) and imaged with a CCD camera (Nikon D50) with a shutter speed of 1/15 of 
a second.  An amber screen included with the transilluminator was placed between 
the CCD and the device. 
 
2.5 Results 
2.5.1 Direct DNA extraction and amplification:  protocols and validation 
New protocols were developed to isolate DNA from tissue and then to proceed 
directly to PCR amplification in the wells of the device.  This “single tube” approach 
simplifies the currently-used process of detecting genes from tissue, which requires 
centrifugation and sample pipetting between multiple tubes.  These techniques were 
initially validated because the device, protocols, and reagents were new.  Also, the 
inclusion of 2% agarose and the small aluminum wells created a novel environment 
for PCR that necessitated a comprehensive evaluation of system performance.   
 
2.5.1.1 DNA extraction protocol 
DNA was extracted directly using water and proteinase K, since the carry over of 
additional buffer salts is known to inhibit PCR reactions.  To prepare the wells for the 
addition of extraction solution, the agarose and tissue were dehydrated within the 
device using the heating rig at 95 °C for 5 minutes.  To isolate the DNA, the cells 
were lysed in water mixed with proteinase K (Invitrogen 25530-049) at 2 mg/mL 




To prepare for device sealing, the reagents were dehydrated at room temperature for 
10 minutes and then frozen at -20 °C for 10 minutes.  The device was sealed and 
heated to 65 °C for 30 minutes to digest the tissue and 95 °C for 5 minutes to 
inactivate the enzyme.  The well contents were then solidified and dehydrated.   
 
2.5.1.2 Validation of DNA extraction protocol 
The direct DNA extraction protocol was tested using frozen normal prostate tissue 
that had been snap frozen to a glass slide.  Tissue scrapes were placed into 12 
randomly chosen wells.  The tissue was diluted to 6.7 ng/µL in the extraction 
solution.  The tissue-proteinase K mixture was subjected to the DNA extraction 
protocol, except without the addition of agarose.   
 
Controls were then added to other wells to semi-quantitatively gauge the efficacy of 
the direct DNA extraction procedure.  First, genomic DNA (BioChain Institute, 
D1234106) was added as a dilution series of 1.06 ng/µL, 212 pg/µL, and 42 pg/µL, 
which represents a range of easily detectible to non-detectible levels of starting 
material.  Water was also added to provide a negative control.  The contents of the 
wells were dehydrated as described previously and subjected to PCR.  Validation was 
performed by gel electrophoresis at 100 V for 35 minutes in a 2% gel (NuSieve 3:1) 






An electrophoresis gel (see Supplementary Materials for a photo of the gel) showed a 
167 bp DNA fragment from both purified genomic DNA controls above 212 pg/µL 
and from prostate tissue, but not from the negative control.  Furthermore, the 
observed amplified bands from prostate tissue were of identical size to those from 
genomic DNA owing to the specificity of PCR.  These results demonstrate that the 
frozen prostate tissue was lysed and the DNA was amplified in the multi-well device 
without additional purification steps.   
 
2.5.1.3 Validation of DNA amplification protocol 
To test that PCR was reliable and robust in the agarose-filled aluminum miniature 
well environment, a variety of amplifications were carried out simultaneously in 12 
wells of the device.  Two templates (sources of DNA) were used. 
1. Human OsteoSarcoma cDNA at 4.9 ng/µL made from mRNA (Ambion Inc., 
AM7868) by a standard reverse transcription protocol. 
2. A 582 bp PCR target amplified in a thin-walled PCR tube to 5x109 molecules/µL. 
Four sequences on the first template were targeted, and the second template was 
diluted to four different concentrations.  The PCR products were run on an 
electrophoresis gel (see Supplementary Materials).  All the observed gel bands 
corresponded to primers added to the wells.   
 
In these results a well filled only with water was immediately adjacent to a well that 
contained previously-amplified PCR targets at a high concentration.  The fact that no 




contamination between wells.  The PCR amplification was effective for both purified 
targets and mixtures containing many non-specific targets.  Taken together, these 
results demonstrate that PCR within the wells robustly amplifies a variety of targets 
from a variety of templates including crude genomic DNA, crude cDNA, and PCR-
amplified products. 
 
2.5.2 2D-PCR mapping 
To validate the concept of 2D-PCR, the presence or absence of specific DNA 
sequences in tissue sections was mapped as a first step towards the more desirable 
quantification of DNA by real-time PCR methods.   To this end, a genomic DNA 
target sequence (GAPDH) in a breast tissue section was mapped and correlated with 
the known geometry of the histology.  The GAPDH gene is present in the nuclear 
DNA sequence of every cell, and is thus found throughout the tissue.  The map would 
therefore be expected to show where the tissue was present above the device.  Using 
the 2D-PCR approach, a GAPDH genomic DNA target from breast tissue was 
extracted, PCR amplified, and visualized by SYBR Green I with 1.6 mm resolution.   
 
2.5.2.1 2D-PCR mapping protocol 
To identify the tissue area visually, the sample was stained pink with Eosin Y.  The 
tissue was transferred onto the device surface and imaged (Figure 12).  It was then 
pressed into the wells and dehydrated.  The tissue was then lysed to release the DNA 
as described in the DNA extraction protocol, with the proteinase K concentration 




and square notch were cut out of the sealing film covering the tissue.  After 
dehydration, the GAPDH target region of genomic DNA was amplified.  After PCR, 
the sealing film was removed.   
 
SYBR Green I dye was added.  Solidifying the DNA in agarose enabled the DNA to 
be stained with SYBR Green I dye without losing the DNA from the wells.  The 
fluorescent image of the device is shown in Figure 12.  Those wells that were under 
the tissue fluoresced, demonstrating that the DNA had been amplified to sufficiently 
high levels.  The wells that were completely under the tissue fluoresced the most.  
The negative control area, which was not covered by tissue, had only a low 
fluorescent background signal.  The detection signal correlated with the known area 
of the tissue, demonstrating that the 2D-PCR approach was successful.   
 
  
Figure 12 – Image of a breast tissue section (stained pink for visualization with Eosin Y) after 
transfer onto the multi-well device, and the visualization map created by fluorescent DNA 
detection with SYBR Green I after amplification by 2D-PCR.  The tissue position is indicated by 





2.5.2.2 Validation of 2D-PCR 
To validate that the fluorescent signals correlated with the desired target 167 bp 
GAPDH PCR product, the well contents were run on an electrophoresis gel.  To do 
this, the device was cooled to 0 °C for 10 minutes to solidify the agarose, and the top 
sealing film was removed.  A pipette (Fisher 02-707-439) was used to obtain gel 
plugs from six fluorescent and six non-fluorescent wells.  Each plug was diluted 100 
times with water and melted at 95 °C for 10 minutes to dilute the Eosin dye.  Then, to 
offset the dilution, each sample was amplified by 8 cycles of PCR (110 fold 
amplification at 90% efficiency) using the same PCR conditions as previously 
described.  Samples were subjected to electrophoresis at 100 V for 35 minutes in a 
2% gel containing 1X TBE and 1X SYBR-Gold dye. 
 
A signal corresponding to the 167 bp GAPDH genomic DNA target was observed in 
lanes 1-6, which correlates with the presence of tissue (Figure 13).  There were no 
observed false positives from wells without tissue (lanes 7-12).  Note that the 
negative well 9 was directly adjacent to wells covered by tissue, yet there was no 
observed cross-contamination.  These results confirm that the 2D-PCR method can be 
used to isolate tissues, extract DNA, amplify DNA, and visualize DNA in a spatially 






Figure 13 – A) The wells chosen for electrophoretic validation of the fluorescent signal.  B) In 
wells containing tissue (lanes 1-6) there was a bright fluorescent signal corresponding to 
detection of a 167 bp GAPDH genomic product, while negative wells (lanes 7-12) had no 
amplification of the 167 bp target and only weak bands of ~50 bp primer-dimers, an artifact 
from PCR.     
 
2.5.3 Preliminary work towards miniaturization 
A longer term goal of this research is to create a tool with well sizes of 50-100 µm, 
which would produce 2D maps with a resolution of ~100 cells.  Such miniaturization 
has challenges associated with microfabrication, sample loading, rapid fluid 
evaporation, lower amplification efficiency, and smaller volumes for fluorescence 
visualization.  We have performed some preliminary studies to identify a path to 
miniaturization.  We describe these steps briefly here and give further details in the 
Supplementary Materials.   
 
Standard microfabrication with deep reactive ion etching (DRIE) in silicon allows the 
realization of through-hole wells that are tens of µm in diameter.  Multi-well arrays 
were fabricated in Si using DRIE.  They had wells that were 100 µm in diameter and 
400 µm deep (the thickness of the wafer); they were spaced 100 µm apart, yielding 






Figure 14 – Silicon substrate having a 1 cm square area with 100 µm diameter holes spaced 100 
µm apart.  The surface was pretreated with BSA and spotted with water containing food dye for 
visualization (dark area in center).  The wells filled completely by capillary action.       
 
It is not possible to pipette reagents into such small wells, but fluid can be pulled into 
the wells by capillary forces if a wetting agent is added to make the etched walls more 
hydrophilic.  Placing a droplet of water containing BSA, Triton X-100, or Tween 20 
of an appropriate concentration (see Supplementary Materials) onto one side of the 
micro-well plate and allowing it to dry resulted in subsequent complete filling of the 
wells by both aqueous solutions (Figure 14) and agarose solutions up to 
concentrations of 1.5%.  None of these surface treatments inhibited PCR, consistent 
with prior work 22, 122.   
 
The micro-wells must be sealed to prevent spreading and/or evaporation of reagents.  
This requires a material that conforms to surface variations of the plate to create a 
good seal, yet that at the same time is not so viscoelastic and adhesive that the sealing 
material embeds itself permanently into the holes, preventing reversible sealing.  




of the micro-well plate, and it also prevented 99.8% of crosstalk (Supplementary 
Materials).   
 
To demonstrate PCR in the micro-well plate, the surfaces were pretreated with BSA 
and loaded by capillary action with a PCR mastermix containing a primer set and 
cDNA that had been used previously in the mini-vials, as well as additional native 
Taq DNA polymerase and additional BSA.  The additional BSA is needed with large 
surface to volume ratios to prevent nonspecific adsorption on the walls of the wells.  
For the negative control, water was substituted in place of cDNA.  No gel was used in 
the wells here, so preventing evaporation was particularly important; the micro-well 
plate was sealed using Microseal A.  The micro-well plate was placed on the flat 
alpha unit block of the thermocycler, covered with mineral oil to maximize thermal 
contact, and thermally cycled.  For validation, the fluid within the vials was recovered 
and combined, and loaded onto a 1.5% agarose electrophoresis gel.  The gel results 
(Supplementary Materials) verified successful PCR.  
 
2.6 Discussion 
Several challenges in using the multi-well array approach were overcome to obtain 
the DNA mapping results presented here.  The first was transferring tissue into the 
device while segregating tissue subregions (or “pixels”) to preserve overall spatial 
information.  The second was creating a new single-well protocol for extracting the 
DNA, amplifying the DNA, and detecting the amplified DNA.  The third was creating 




evaporation between wells.   The current 2D-PCR technology is now ready for 
optimization to study specific alterations in DNA, such as LOH, SNPs, and 
methylation using methylation-specific PCR 35.    
 
Lab-on-a-chip devices typically use microfluidics on a planar surface to interconnect 
processing chambers for isolating and amplifying DNA from cells 123-125, but this 
consumes too much space on the chip surface to map DNA from tissues with practical 
density.  The single-well procedure for processing samples eliminates the need for 
fluid movement while providing direct surface access to capture as much tissue as 
possible.   
 
The first challenge was addressed by loading the tissue vertically, pressing it directly 
into the array of wells to isolate tissue subregions while preserving the overall 2D 
spatial relationship.  Even though tissue remained on the top of the device between 
the wells, the 2D-PCR results demonstrated that this tissue does not contribute a 
signal to the adjacent wells.  This tissue loading technique also has the advantage of 
beginning with traditional histological sectioning and transfer steps, which are 
familiar to investigators and clinicians who may wish to adopt this technique for 
research or diagnosis. 
 
A new approach was used to extract DNA from tissue, amplify it, and detect the 
amplification products with fluorescence visualization.  We used a direct DNA 




inhibiting subsequent PCR.  Afterward, the PCR products were stained directly with a 
fluorescent DNA-intercalating dye.  This approach streamlines the protocols used in 
commercially available kits, which require centrifugation and re-pipetting of each 
sample between three to four tubes 48, 52, 86, 126, 127. Performing the processes 
sequentially in a single well not only enables a simple device geometry but is also 
amenable to further miniaturization.  Others have also realized the importance of 
simplifying and/or miniaturizing commercially-available nucleic acid processing 
protocols by using fewer steps, tubes, or reagents 87, 94, 123-125, 128-134, but those 
techniques do not make it possible to map DNA from tissue.   
 
Directly visualizing the PCR products by staining them with fluorescent dye allows 
them to be detected across the entire array, creating 2D maps both efficiently and 
directly in situ.  There is sufficient DNA in an 8 µm thick tissue sample for detection 
in a single 1.6 mm diameter well.  Given the facts that there were at most 5,000 cells 
captured per well, that the detection signal was strong, and that detection occurred at 
35 cycles, it is anticipated that 2D-PCR can be extended to the level of about 100 
cells per well – a limit we expect due to the efficiency of DNA extraction with this 
method rather than PCR sensitivity (which has been shown to amplify DNA even 
from single cells 135).  In the future, it would also be desirable to use real-time PCR to 
detect the PCR products, eliminating the staining step, as others have demonstrated 
136.  It is also possible to detect the products by fluorescent hybridization after blotting 





The single-well protocol depended on a new reversible sealing procedure to contain 
the samples across an array format and to enable the addition of successive reagents.  
Without sealing, reagents can evaporate or spread during the heating steps.  The 
vapor was contained within the wells by applying compression to a sealing film 
placed on top of the entire multi-well array.  Suppliers of 96-well or denser multi-well 
plates also employ reversible seals to prevent evaporation of the water, but this is the 
first example of reversible sealing across an array of holes in a flat surface.  PCR lab-
on-a-chip reactors typically employ irreversible seals, such as nail polish or epoxies, 
to attach glass cover slips onto silicon PCR wells 108, 122, 136.  Reversible sealing was 
used for 2D-PCR because different reagents needed to be added and dehydrated at 
different times.  This method of sealing was successful with both the aluminum and 
the silicon substrates.   
 
Sample containment also relied on the addition of 2% agarose gel to the wells before 
the tissue transfer step to prevent the movement of fluid and to immobilize the DNA.  
PCR has not previously been reported in the presence of greater than 0.5% agarose, 
although there have been reports of up to 3% agarose used with other biological 
enzymes 121.  We note that it is also possible to prevent mixing by freezing the fluids 
prior to seal removal, but the resulting condensation can prevent future sealing. 
 
It is also of interest to miniaturize the device presented here to provide biomolecular 
information at the level of a few dozen cells, which would allow pathologists to 




function of cell type.  We have solved some of the challenges of such miniaturization, 
but significant challenges still need to be overcome.   The greatest challenge will be 
transferring tissue into the micro-wells in such a way that the tissue does not block 
the openings, preventing future transfer of fluid.  Solutions to this issue may include 
electro-transfer of DNA from tissue lysates or using a more disruptive tissue lysing 
process.  Another major challenge is designing a batch fluid-loading system that is 
consistent, prevents cross-contamination between wells, and avoids uneven 
evaporation.   
 
We are currently working on mapping RNA from tissue, since current visualization 
techniques for RNA cannot reliably detect below a few dozen copies per cell in situ 
70, 71.  There are many techniques that can currently detect high abundance targets 
directly in a tissue section, but based on recent publications and personal accounts of 
researchers in the field, these techniques have failed for lower-abundance targets 
because they are either unreliable, difficult to reproduce, or too time-consuming.  On 
the other hand, the robustness of LCM has led to widespread acceptance because it 
can be used to study small cell populations with reliable down-stream techniques.  
Unfortunately, LCM is only employed to study a limited number of cell populations 
because of time and cost constraints.  Thus, a promising new way to address the need 
for mapping low abundance genes is via the 2D-PCR method presented here.   
 
2D-PCR opens several other promising avenues for technical research.  One ideal 2D-




(FFPE) tissue samples in addition to frozen samples.  FFPE tissue represents the 
majority of clinical tissue samples available for study, but these samples contain 
fragmented and immobilized RNA due to the formalin cross-linking.  The technique 
could also be extended to other 2D samples, such as Southern blot gels, to improve 
the detection limits and post-staining specificity.  Finally, in the future, it would also 
be desirable to use quantitative real-time PCR (qPCR) to detect the PCR products, 
eliminating the staining step as others have demonstrated 136.  To account for 
variations in the number of cells loaded, the PCR would need to be multiplexed to 
include housekeeping genes to which other signals could be normalized.  However, 
qPCR machines that would be compatible with the setup presented in this work are 
not commercially available and would require a significant effort to customize.  
 
Currently, biological research is growing with respect to the number of genes and 
number of patients studied, but it suffers from slow growth with respect to 
comprehensive tissue analysis.  Therefore, a potentially promising avenue for future 
work is facilitating human genetic anatomy research that would create gene 
expression maps of human tissue.  This can be applied to study tissue heterogeneity 
and tumor microenvironments, to map the extension of the molecular field effect 
from cancer into normal regions (the “histological margins of tumors” versus the 
“molecular margins”, which can have potential clinical use in the surgical resection of 
neoplasias), and to the study of the molecular anatomy of normal and pathological 





It would be possible to use the 2D-PCR method to create 3D maps of tissue.  By 
combining information from a number of serial cut tissue sections taken from a single 
tissue block, one can create 3D maps8.  To facilitate this process, the sample handling 
should be automated.  The practicality of 3D mapping will depend on how quickly, 
easily, and cheaply the 2D PCR can be performed, a goal for future work.   
 
The spatial genetic data may also elucidate the normal function of human genes, 
which is known for only 30% of them 137.  To highlight the interest in mapping gene 
function in tissues, there have been several initiatives for procuring and archiving 
gene expression images on the mouse, including BGEM 138, Brainatlas 139, Genepaint 




We have developed a novel approach for creating maps of DNA preserving the 2D 
architecture of the tissue based on extracting the nucleic acids from a tissue section 
and then amplifying them within a controlled environment in such a way that the 
positional information is preserved.  To validate this method, we demonstrated that 
DNA could be mapped from a frozen human tissue section, a result that represents 
over a hundred successful DNA isolations and subsequent PCR reactions performed 
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2.9 Supplementary Materials 
The supporting information includes a figure showing the pressure compression rig, 
the electrophoresis gel validations of the 2D-PCR method, and complete details of the 
miniaturization studies, including the microfabrication, reagent loading by capillary 
action, cross-talk studies, demonstration of PCR, and discussion. 
 
 
2.10 Supplementary Information for Mini-Vial Results 
2.10.1 Compression Rig 
The compression rig that was used to ensure sealing during thermocycling of the 






Figure 15 – Schematic view of the compression-heating rig used for sealing and thermocycling.     
 
2.10.2 Electrophoresis Gels for Validation of 2D-PCR Method 
Our tissue DNA extraction protocol was verified by the electrophoresis gel results 
shown in the next figure. 
 
 
Figure 16 – Gel electrophoresis from PCR validation experiment.  Lanes 1 and 7 show 50 bp 
molecular weight ladders.  Lane 2 had a negative water control, lanes 3-5 had increasing 





The PCR DNA amplification protocol in the agarose-filled aluminum miniature wells 
was also verified via an electrophoresis gel.  Twelve amplifications were tested 
(Table 8) for the twelve mini-vial locations shown in Figure 17a with the resulting 
electrophoresis bands in Figure 17b.  All the observed bands corresponded to primers 
added to the wells thus verifying in-well PCR. 
 
Table 8 – Well contents for validating DNA amplification. 
Well Contents Concentration Target Primers 
1 1. cDNA 78 pg/µL BetaActin – 167 bp 5’tcaccctgaagtaccccatc, 
5’ggtcatcttctcgcggttg 
2 1. cDNA 78 pg/µL BetaActin – 489 bp 5’tcaccctgaagtaccccatc,  
5’ccatctcttgctcgaagtcc 
3 1. cDNA 78 pg/µL GAPDH – 167 bp 5’catcatctctgccccctct, 
5’tgagtccttccacgatacca 
4 1. cDNA 78 pg/µL GAPDH – 582 bp 5’aaatcccatcaccatcttcc, 
5’gcctgcttcaccaccttctt 
5 water -- 
6 1. cDNA 4.9 pg/µL 
7 1. cDNA 20 pg/µL 
8 1. cDNA 478 pg/µL 



































Figure 17 – a) Geometric arrangement of the wells.   b)  Gel electrophoresis validation of DNA 
extraction experiment.  The lane numbers correspond with the well numbers in Table 8.  Lane 13 
had a 50 bp ladder.  The gel lanes show bands at (1) 167 bp, (2) 489 bp, (3) 167 bp, (4) 582 bp, (5) 
no bands, (6) no bands, (7) 582 bp, (8) 582 bp, (9) no bands, (10) 582 bp, (11) 582 bp, (12)  582 bp.     
 
Here all the gel bands corresponded to the primers added to wells.  These results 
demonstrate the robustness of PCR in the device since there was specific 
amplification of four different PCR target regions (lanes 1 to 4).  Well 5, filled only 
with water as a control, showed no bands.  This well was directly next to well 12, 
which contained previously-amplified PCR targets at a high concentration.  The fact 
that no bands were observed demonstrates that there was no cross contamination 
between wells.  To further demonstrate the robustness of PCR, lanes 6-8 contained a 





2.11 Supplementary Information for Further Miniaturization 
2.11.1 Purpose of Further Miniaturization 
The current device was developed with a resolution of 1.6 mm as a proof-of-concept 
for the 2D-PCR approach.  This initial effort demonstrated a substantial improvement 
in resolution (over 100 fold) compared to a whole tissue scrape.  However, our long 
term goal is to create a tool that can map 2D tissue sections for gene expression with 
a resolution of about 100 cells, or well sizes of 50 to 100 µm.  This finer-resolution 
device would have applications in all areas of biology, including developmental 
biology, cellular-level studies of genes expressed at low abundance, and animal 
models.  However, miniaturizing 2D-PCR has the additional challenges of 
microfabrication, batch fluid loading by capillary action, containment of samples that 
evaporate quickly, lower amplification efficiency, and a smaller volume for 
fluorescence visualization.  All of these have been addressed by the preliminary 
studies presented here.  However, the challenges of loading tissues into the smaller 
vials and adding reagents while avoiding cross-contamination have not yet been 
examined.   
 
2.11.2 Challenges Addressed 
2.11.2.1 Fabrication 
Standard microfabrication with deep reactive ion etching (DRIE) in silicon allows the 
realization of through-hole wells tens of µm in diameter, thus providing micro-scale 




comprising 1.3 cm x 1.3 cm areas separated by a 1.5 mm wide border for mechanical 
support on the outer edge.  The wells were 100 µm in diameter and spaced 100 µm 
apart, yielding 2,500 wells/cm2.   The wells had a depth of 400 µm that was 
determined by the thickness of the silicon wafer.  Assuming a biological cell diameter 
of 10-20 µm, and noting that tissue can be sliced down to single cell thicknesses, 
wells of 100 µm could contain nucleic acids from a localized population of just 25-
100 cells from the tissue. 
 
Micro-well plates (Figure 18a,b) were produced from double-side polished, 4” 
diameter, 400 µm thick <100> Si wafers.  SU8-50 (Microchem), a negative resist, 
was used as a mask to protect those areas not to be etched.  After dehydrating the 
wafers at 180 °C for 10 minutes, the SU8 was spun onto the wafer, ramping up to 
2,500 rpm and holding for 40 seconds.  The resist was prebaked at 65 °C for 5 
minutes and 95 °C for 10 minutes, then cooled to room temperature over 5 minutes.  
The SU8 was exposed through a mask that included the 100 µm wells and lines of 20 
µm width between micro-well areas to aid later dicing. The resist was post-baked 
using the same procedures as for prebaking.  The SU8 was developed (MicroChem 
SU8 Developer) for 2 minutes, then rinsed in isopropanol, methanol, and de-ionized 
water.  The wafer was attached to a second “handle” wafer with a layer of spin-coated 
Shipley 1813 resist.  The holes were etched all the way through the wafer by DRIE 
using an etch cycle of 10 seconds and a passivation cycle of 6.5 seconds, for a total of 




Figure 18a,c), and we assume this was due to defects in the SU8 mask.  Lastly, the 
handle wafer was removed in acetone, and the SU8 mask was peeled off.   
 
a)  b)  
c)  
Figure 18 – a) Silicon chip having a 1 cm square area with 100 µm holes spaced 100 µm apart.  b) 
SEM sidewall profile of 50 µm wide holes made by DRIE.  c) Silicon chip with 100 µm holes that 
was pretreated with BSA and spotted in an arbitrary diamond-shaped pattern with water 
containing food dye.  The wells filled completely by capillary action.     
 
2.11.2.2 Loading reagents by capillary action 
Since it is not possible to pipette reagents into these 100 µm wells, capillary action 
was used to draw the fluid into them.  The driving force, F, for capillary action is 
related to the radius of the well, r, by F = 2πrσLGcosθ , where σLG is the surface 
tension of the liquid-gas interface and θ is the contact angle.  If the surface is 
hydrophobic and the contact angle goes above 90°, there is a negative force for filing 




angle.  Several surfactants were tested for their ability to facilitate fluid transfer:  
bovine serum albumin (BSA) (20 mg/mL, BP675-1), Triton X-100 (NC9903183), 
and Tween 20 (BP337-100), each diluted to 0.2%, 1.0% and 5% of their stock 
concentrations in 50% ethanol-water (0.04, 0.2, and 1.0 mg/mL BSA, respectively).  
A 10 µL droplet was coated on one side of the micro-well plate and allowed to dry.  5 
µL of water-based food coloring (for ease of visualization) was placed on the surface, 
and the percentage of filled holes determined (Figure 18c).  The 5% BSA (1 mg/mL) 
and all the Triton X-100 and Tween 20 coatings resulted in complete filling.   
 
The surfactant inhibition limit in PCR was also tested by drying the various 
surfactants in standard PCR tubes.  None of the surfactants inhibited PCR up to the 
5% concentration (from stock) that was tested.  This is consistent with the well-
known observations that Tween 20 stabilizes the Taq enzyme and that surfactants 
such as X-100 or BSA can be used to improve PCR specificity 22, 122.  Since BSA in 
the reaction mix has previously been used for PCR in silicon plates this was the 
surface treatment chosen for the remaining work.  These experiments allow us to 
conclude that the use of 5% BSA allows the transfer of reagents into the wells and 
does not interfere with the PCR processes.   
 
To test the loading of reagents into the (BSA-pretreated) micro-well plate by capillary 
action, samples of molten agarose at 0.5, 1.0, 1.5 and 3.0% weight/volume were 
spotted on four different plates, and each plate was covered on both sides with the 




g weight for even spreading.  The micro-well plate was placed in a 4 °C refrigerator 
for 15 minutes to solidify the agarose.  The agarose could be seen in all of the micro-
wells for concentrations up to 1.5%.  The 3.0% gel hardened too quickly to be drawn 
into the chip by capillary action.  
 
2.11.2.3 Sample containment in micro-wells 
As mentioned in the main text, the micro-wells must be sealed to prevent spreading 
and/or evaporation of reagents (Figure 19).  The challenge is to identify a material 
that conforms to surface variations of the plate to create a good seal yet at the same 
time is not so viscoelastic and adhesive that the sealing material embeds itself 
permanently into the holes, preventing reversible sealing.  A number of sealing 
materials were tested by measuring the fluid loss from a fixed initial fluid volume 
under the same temperature, pressure, and time.  This provided measurements of the 
total percentage of evaporation 1) before loading and 2) after heating. 
 
The sealing materials (Table 9) were rinsed with ethanol and air-dried, then placed in 
contact with one side of the plate.  Before use, the sealing materials were compressed 
at 100 psi and 98 °C for 15 min to reduce their thickness and avoid later plugging of 
the wells.  Wells were filled with aqueous food dye by pre-treating the devices as 
described above and pipetting 8 µL of dye over the wells so that they would be filled 
by capillary action.   The fluid was then frozen by placing the plate on dry ice.  The 
other side of the plate was covered with the same sealing material.  The plate was 




thermocycler heating block, covered in 200 µL of mineral oil, covered with a 1” 
plexiglass block and a 1” aluminum block, and compressed using a custom-built 
pressure rig (100 psi force).  The plate was heated at 98 °C for 15 min, then cooled to 
room temperature.  Temperatures were verified to within 2 °C using a type J 
thermocouple.  The plate was placed on dry ice for several seconds, the top seal was 
pealed off, and the plate was brought to room temperature.  To measure the change in 
fluid volume, the total volume of fluid in the 10 vials was collected with a 30 µL 
pipette tip. 
 
To determine fluid loss in micro-wells, plates were photographed with a digital 
camera using a macro lens before and after annealing, and the images analyzed with a 
custom-designed MATLAB script.  The results are summarized in Table 9.  
Microseal A prevented evaporation of reagents from most of the micro-well plate, 
and it prevented 99.8% of crosstalk.  Thus, for the micro-wells, Microseal A is the 
best choice, since preventing crosstalk is essential.  The sealing process still requires 
some additional optimization to consistently and uniformly prevent evaporation 






Figure 19 – Compression-thermocycling rig showing PCR machine on a weight scale.    
 




Description Evaporation Spreading Comments 
Parafilm thick, viscoelastic  N/A N/A plugs wells 
Microseal A clear, proprietary  ~11% <1%   








Adhesive FEP adhesive fluoropolymer 0% ~5%   




To demonstrate PCR in the micro-well plates, they were pretreated on one side as 
previously described and then loaded by capillary action with 8 µL of the following 




polymerase, 3.5 µL of 25 mM MgCl2, 250 µM of the 587bp GAPDH primer set, and 
1 µL of the cDNA (5 ng/µL) used previously, as well as an additional 2 mg/mL BSA.  
A second PCR supermix contained the same reagents with 1 µL of water in place of 
cDNA as a negative control.  Since no gel was used in the wells here, particular 
attention had to be paid to prevent evaporation.  The micro-well plates were sealed as 
described above using Microseal A.  The micro-well plate was then placed on the flat 
alpha unit block of the thermocycler, and covered with mineral oil.  PCR was 
performed with the following parameters:  95.0 °C for 2 min, 30 repeated cycles of 1) 
95.0 °C, 30 sec, 2) 56.0 °C, 30 sec, and 3) 72.0 °C, 45 sec, followed by 72.0 °C, 2 min, 
and cool down to 4 °C, 10 min.  The pressure lid was removed and the sealed plate 
was placed on dry ice.  The seals were removed within a box containing dry ice.   
 
To yield enough sample for visualization on an electrophoresis gel, the fluid in all of 
the micro-wells was combined.  To extract the fluid, the mini-well plate was broken 
into pieces, placed in a 1 mL tube with 50 µL of 50% ethanol-water, shaken, and 
heated to 70 °C for 5 minutes.  The recovered fluid was dried at 95 °C to remove the 
ethanol and reconstituted with 10 µL water to match the original reaction volume.  
This mixture was combined with 2 µL of concentrated gel-loading buffer and loaded 
onto a 1.5% agarose electrophoresis gel for validation.  A second pair of positive and 
negative PCR controls performed in a test tube were also included.   
 
As expected, the positive micro-well control and the standard plastic tube control 




primer-dimer bands were observed (Figure 20).  The negative control plate showed 
no band at 587 bp, for either the test-tube negative control or micro-well plate 
negative control.  A fifth lane was included containing unamplified PCR super mix.  
These results confirm that we can perform PCR in the silicon micro-well plates, 
which was expected given the prior work by others 108, 122, 136.  The band intensity is 
weaker from the micro-well plate, and it is not clear whether this is an artifact from 
the fluid recovery method or if the micro-well plates perform somewhat less 
efficiently than standard plastic tubes.   
 
 
Figure 20 – PCR results from (lane 2) a standard plastic PCR tube with control DNA added, (3) 
a micro-well plate with control DNA added, (4 and 5) a plastic tube and another micro-well plate 
containing only water, and (6) a lane containing unamplified PCR supermix.  Lanes 1 and 7 
contained 50 bp ladders.     
 
If our technology was able to map and quantify the levels of nucleic acids, rather than 
just detecting target molecules above or below a pre-determined threshold, it would 
be more valuable.  This capability would potentially be useful for applications such as 
clinical determinations of tumor margins or identifying cancer in biopsies.  




question concerning qPCR in micro-wells is whether there is enough volume for 
fluorescent detection of PCR products with standard fluorescent imaging machines.  
To address this question, we loaded micro-wells with previously amplified PCR 
products containing either TaqMan or Sybr-Green I fluorescent probes, and imaged 
the devices using a Typhoon 9410 set to 10 micron resolution.  There was a 
measurable and clear difference in signals between positive and negative controls 
(Figure 21).  In another plate (not shown) run with SYBR gold probe chemistry, there 
were similar results, indicating feasibility at the microscale. 
 
a)   b)   c)  
Figure 21 – TaqMan in 100 µm micro-wells, looking at different areas on one plate.  a) Strong 
positive control with Ct value of 24.  b) Negative control with no Ct value.  c) Strong positive 
control with Ct value of 29.69.     
 
The image pixel intensities were directly related to the amount of DNA.  These 
results demonstrate that it should be practical to use quantitative real-time methods 
(Ct values, point of curve inversion) to determine the approximate initial expression 
level of mRNA in single wells of a multi-well device.   
 
2.11.4 Discussion of Miniaturization Results 
These preliminary results demonstrate that extending the 2D-PCR concept to 
miniaturized devices, which have 256 times the well density, requires further 




in volume (2.4 nL) than our aluminum device (2.4 µL), there was still enough fluid 
volume to detect a strong positive signal from post-PCR products, and a clear 
difference in signal between positive and negative samples.  The PCR efficiency in 
these devices still remains to be determined.   
 
In the future, work will focus on loading tissue and reagents into these wells.  In 
particular, the silicon device needs a stronger inner hydrophilic coating and a stronger 
surface hydrophobic coating, both to prevent evaporation of fluid and to prevent 
spontaneous wicking of fluid out of the wells.  Tissue loading may suffer from 
clogging of the wells, which would prevent subsequent loading of reagents by 
creating an air bubble that prevents fluid movement by capillary action.   
 
2D-PCR is expected to be scalable because the single-well procedure requires no 
pipetting of reagent out of the wells, enabling reagents to be added by capillary 
action.   Since the volume of sample is always proportionate to number of cells, we 
do not expect a loss of efficiency in these devices when trying to amplify the same 
concentration, even if there is smaller number of transcripts per well.  To support this 
hypothesis, the results of testing quantitative fluorescent dyes showed that there was 





Chapter 3: RNA maps from frozen tissue 
Nucleic Acids Research, full article, draft 
 
In this chapter, the methods and results for mapping and quantifying mRNA from 
frozen tissue sections are presented, as described in aim 2.  This chapter presents 
these results as the entirety of a manuscript still in preparation, which is expected to 
be submitted for publication to Nucleic Acids Research Methods Online. 
 
Intellectual contributions:  I drafted the initial manuscript, performed all of the 
experiments, and developed the experimental methodology (see intellectual 
contributions 3-4 in Chapter 7).  The co-authors on the paper served an advisory role 
by guiding the project and helped to edit and finalize the manuscript for submission. 
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The ability to visualize nucleic acids across a tissue sample would lead to a greater 
understanding of the biological function of genes.  This requires a high-throughput 
process to prepare tissue for PCR and to perform the amplification while maintaining 
the layout of individual tissue subregions.  In this paper we present 2D-RT-PCR, a 
method for performing cell lysis, nucleic acid purification, and quantitative RT-PCR 
amplification across a tissue section while maintaining spatial relationships.  A 
single-well protocol for tissue lysis and nucleic acid purification was developed that 
is as efficient as commercially available bench-top scale reactions and that has greater 
consistency and lower detection thresholds.  It uses a GITC-based buffer and works 
with as little as 5 µL of starting lysate.  As an example of the utility of this method, a 
frozen tissue section containing mouse liver, kidney, and heart was mapped in 










The standard approach for understanding the biological role of nucleic acids is to 
visualize proteins and nucleic acids by in situ staining techniques.  In situ staining 
includes the “gold standard” Hematoxalin and Eosin (H&E) staining, protein staining 
by immunohistochemistry (IHC), and nucleic acid staining by in-situ hybridization 
(ISH).  However, IHC and ISH have poor sensitivity, as exemplified by difficulties in 
using these techniques to obtain a clinical diagnosis13-15, 17, 80, 81, 99.   To address this 
need for greater sensitivity, in situ PCR was invented in the early 1990s, combining 
the benefits of PCR amplification with subsequent staining of PCR amplicons in 
situ
82.  Despite initial excitement over the technique, in situ PCR proved to be too 
variable to consistently amplify many desired targets within a range of complex tissue 
milieus13-15, 63, 84, and it has been found that the in situ PCR technique is best suited 
for detecting high-abundant targets such as virus DNA 85. 
 
Researchers who seek to both quantify and localize nucleic acids have first isolated 
tissue subregions and then performed PCR on each subregion separately.  For 
example, brain tissue has been cut into a grid on the mm scale using the voxelation 
method18, and larger regions of tissue have been manually isolated using 
macrodissection90, 91.  The approach has provided significant useful information by 
maintaining the spatial information concerning the source of the nucleic acids.  Laser 
microdissection is another technique for isolating subregions from a tissue section, 
but it does so on the length scale of individual cells8, 10, 65.  However, this approach is 




Microdissection typically involves a four-step workflow of macrodissection, tissue 
homogenization and lysis, RNA purification, and RT-qPCR. 
 
We have previously demonstrated 2D-PCR for mapping genomic DNA across a 
tissue section 100.   This approach married the desirable features of in situ 
measurements with the advantages of solution-based molecular analysis.  In 2D-PCR, 
the tissue section is transferred into a multi-well plate, using the grid format of the 
plate to mechanically subdivide the entire section at once.  Simultaneously within all 
the wells, the tissue subregions are lysed and the DNA is amplified.   
 
In this paper we present a version 2D-PCR, 2D-RT-PCR, that performs the more 
complex task of mapping and quantifying mRNA.  The technique includes RNA 
purification, reverse transcription, amplification and qPCR (Figure 22).  After 
showing experimental proof-of-concept, we introduce a new single-well tissue lysis 
and RNA purification method that enables the use of a chaotropic buffer with 
ChargeSwitch magnetic purification beads.  We then demonstrate the utility of the 
single-well technique combined with 2D-RT-PCR as a high-throughput approach to 
quantifying three organ-specific mRNAs across a tissue section containing three 















Figure 22 – 2D-PCR is achieved by transferring a tissue section vertically into a multiwell array 
device, thereby isolating tissue sub-regions.  RNA is extracted by cell lysis, captured and purified 
on ChargeSwitch beads by rinsing steps, and quantified by one-step reverse-transcriptase PCR 
in each well.  Visualization of targets is performed within the wells using standard molecular 
probe chemistry.   
 
3.3 Materials and Methods 
3.3.1 Quantitative PCR Primers and Probes 
Multiplex PCR primers and hydrolysis probes for mouse GYS2, KCNJ1, and HPRT1 
targets (see section 3.7.1) were generated using the Primer3 web application, version 
4.0144.  Primers and probes were obtained from Biosearch Technologies[ESI].  The 5’ 
and 3’ fluorophores ordered for each probe were Quasar 670/BHQ-2 for HPRT1, Cal 
Fluor Orange 560/BHQ-1 for GYS2, and FAM 520/BHQ-1 for KCNJ1.   
 
3.3.2 Tissue Sections and Scrapes 
Frozen mouse liver, kidney, heart, and brain organs and chicken thymus glands were 




organs were embedded in O.C.T. Compound (Tissue-Tek) in a cryostat at -24 °C.  
Tissues were sectioned to 10 µm thickness using a Leica cryostat microtome.  Tissue 
scrapes were obtained by sectioning tissue onto glass slides, heating the slide at 90 °C 
for 30 seconds, and scraping the dried tissue using a razor blade into tubes. 
 
3.3.3 Materials and Equipment 
Heat-activated adhesive film ARSeal 90697 was provided by Adhesives Research.  
Industry standard 384-well clear PCR plates were utilized (Applied Biosystems, 
4309849); each well had a volume of 40 µL.  A Sorval RT7 swinging bucket 
centrifuge was used with these plates.  In place of a multiplexing real-time PCR 
machine, plates were imaged on a Tecan Infinite 200 fluorescent microplate reader as 
described in section 3.7.4. 
 
3.3.4 Buffers and Commercial Purification Kits 
A custom lysis buffer was prepared that contained 3.33 mL guanidinium 
isothiocyanate (GITC, 6 M, Fluka Part 50983), 1.1 mL Triton X-100 (MPBio part 
807426), 5 µL 2-mercaptoethanol (Sigma M3148), and 565 µL double-distilled 
water.  Buffer RLT was obtained from Qiagen (RNeasy kit).  Extraction buffer was 
obtained from Molecular Devices (PicoPure RNA extraction kit).  ChargeSwitch 
lysis, magnetic binding, wash, and elution buffers were obtained from Invitrogen 




prepared according to the manufacturer’s protocol (ABI, AM1005M) and included 
final concentrations of 250 nM primers and 125 nM probes.   
 
3.3.5 Determination of Nucleic Acid Purification Efficiency 
Sheared herring sperm DNA (10 µg/µL, Invitrogen 15634-017) was added to the lysis 
buffers of different purification kits (specified in section 3.4.1).  The loading ranged 
from 2.5% to 50% of the maximum binding capacity of the purification system.  
Amounts of input and recovered DNA were measured in triplicate using a Nanodrop 
Spectrophotometer (Themo-Scientific) using a test volume of 1 µL.  The efficiency 
was calculated as the 100 * recovered DNA * recovery-volume / [input DNA].   
 
3.3.6 2D-PCR Method 
The 2D-RT-PCR method is illustrated in Figure 23.  The tissue section is transferred 
onto an adhesive film, placed tissue-side down over a multi-well plate, and sealed.  
The plate, which has wells pre-loaded with lysis buffer, is inverted to distribute the 
lysis solution over the tissue.  An incubation is performed.  Magnetic ChargeSwitch 
beads are added, which bind the nucleic acids.  A magnet is brought close to the 
wells, attracting the beads and holding them in place for RNA purification by 
washing and DNase treatment steps.  One-step reverse-transcriptase PCR mix is 
added to the wells, and thermocycling with real-time detection is used to quantify the 




at each well location, which corresponds to histological subregions of the tissue 
section. 
 
Figure 23 – Cross-sectional schematic illustration of 2D-RT-PCR method.  A) Tissue transfer.  B) 
Tissue lysis.  C) Addition of magnetic beads.  D) Purification by washing, DNase.  E) 
Amplification by qPCR. 




3.3.7 Optimal 2D-PCR Protocol for Quantifying mRNA Across Tissue Sections  
3.3.7.1 A) Tissue Transfer 
Wells of a 384-well plate were loaded with 5 µL of lysis buffer (either custom GITC 
buffer, section 3.3.4, or others).  Tissues were sectioned (section 3.3.2) and covered 
with a 40 mm x 40 mm piece of heat-activated adhesive film, to which the tissue 
adhered.  Tissues were dried at 50 °C for 2 minutes, rinsed in a bath of 70% ethanol 
for 2 minutes (containing either 1% Eosin Y or 1% Acid Fuchsin Red stains for 
visualization), and dried at room temperature in a fume hood for 10 minutes.  The 
tissue was placed face-down onto the PCR plate.  To seal the adhesive film against 
the plate, the adhesive was activated by a combination of 200 pounds of compressive 
force and 90 °C heat for 5 minutes 100.   
3.3.7.2 B) Tissue Lysis 
After sealing, the plate was cooled to room temperature for 2 minutes.  To distribute 
the lysis buffer over the tissue at the top of the wells, the plate was inverted.  To 
provide a flat, heated surface for incubating the tissue in the lysis buffer, an 8 mm 
thick aluminum block was placed on top of a thermocycler heating plate.  The back of 
the plate was covered with a rubber pad, and the plate was compressed as described 
previously to keep fluid from leaking.  The contents of the wells were incubated for 
15 minutes, applying 60 °C on the tissue side and 70 °C on the back side to prevent 
condensation.  The plate was cooled to 30 °C and centrifuged at 3000 rpm for 3 




3.3.7.3 C) Nucleic Acid Isolation 
To isolate the released nucleic acids, acidic buffer containing magnetic capture beads  
was added to each well (15 µL of 0.33 µL ChargeSwitch magnetic beads, 0.4 µL 
acetic acid, 5.75 µL ChargeSwitch binding buffer, and 8.52 µL water).   
3.3.7.4 D) Purifying the RNA 
To purify the RNA, the magnetic beads were immobilized against a magnet and the 
fluid removed.  For the first rinse, ChargeSwitch wash buffer 13 (20 µL) was added 
to each well and removed.  ChargeSwitch DNase buffer (15 µL) with DNase I  (0.15 
µL) was added and incubated (10 minutes at room temperature).  ChargeSwitch 
binding buffer B9 (5 µL) was added to each well, and the plate was sealed (ARseal 
90697 at 90 °C for 1 minute).  The plate was inverted several times to mix the 
contents, after which the plate was centrifuged as before.  The DNase buffer was 
removed, and two washes were performed using ChargeSwitch wash buffers 13 and 
14, respectively (20 µL).  To isolate DNA from frozen tissues, the DNase step is 
omitted.   
3.3.7.5 E) Quantification Using PCR 
To quantify RNA across the multi-well plate, PCR reagents were added to each well 
and the plate thermocycled and imaged according to standard procedures.  First, the 
wash buffer from the previous step was removed.  Ag-Path ID one-step PCR mix was 
added was added to each well of the plate (5 µL).  Amplification was performed by 
thermocycling (50 °C for 10 minutes, 95 °C for 10 minutes, and 30 total cycles of 95 
°C for 15 seconds and 60 °C for 30 seconds).  The plate was imaged on the 




Threshold cycles of detection (Cts) were determined using a standard curve formula 
(See section 3.7.4).   
 
3.4 Results 
3.4.1 Validation of Efficient Purification at Small Scales 
In order to test an initial proof of concept of 2D-PCR using 384-well plates, a lysis 
and purification protocol was required that would work within those 40 µL well 
volumes.  Since it uses magnetic beads instead of purification columns, the 
ChargeSwitch purification kit was chosen for adaptation.  Those reactions are based 
on volumes of 800 µL, however, so the feasibility of scaling this protocol down 20-
fold had to be established.  Furthermore, because the ChargeSwitch protocol 
recommends repipetting in each well, which would be too laborious across a 384-well 
plate, vortexing of magnetic beads was tested in place of repipetting.  To provide two 
points for comparison of our protocol, the efficiency of another purification kit, 
PicoPure, was also determined.   
 
Sheared DNA was selected as the input nucleic acid because it is a closer 
representative of RNA than unsheared DNA, but unlike RNA it is stable and 
inexpensive enough to be used for quantification purposes at the level of 50 µg per 
sample.  It was assumed that relative recovery efficiencies would be similar for 
sheared DNA and RNA.  Sheared DNA was spiked into the lysis buffer (this 




capacity of the beads (ChargeSwitch – 1 µg/µL) or purification column (PicoPure - 
100 µg).  Loadings throughout this range are typical in the literature. 
 
After the purification (step D), elution buffer was added to the tubes to recover the 
DNA and obtain purification efficiency.  Experiments were performed at least three 
times to determine variability.  The results are shown in Table 10. 
 
Table 10 – Rows 1-4:  Comparison of sheared herring sperm DNA recovery efficiency with 
two commercially available kits: CS – ChargeSwitch Total RNA Cell Kit, PP – PicoPure.  
Rows 5-6:  Recovery efficiency of 20x scaled-down ChargeSwitch protocol.  Rows 7-9: The 









1 PP 2.5 100 31 11 3 
2 PP 50 100 8 3 3 
3 CS 2.5 100 86 3 3 
4 CS 50 100 47 7 3 
5 CS/20 2.5 5 86 12 3 
6 CS/20 50 5 30 4 6 
7 CS/20 + 1% AA 50 5 50 3 3 
8 CS/20 + 2% AA 50 5 38 1 3 
9 CS/20 + 4% AA 50 5 37 2 3 
* Load as a percentage of the reported maximum nucleic binding capacity of the kit. 
 
The ChargeSwitch (CS) protocol yielded more DNA than the PicoPure (PP) protocol, 
but for both kits recovery efficiencies were higher at 2.5% loading than at 50%.  At 
2.5%, the 20-fold scaled-down protocol provided the same purification efficiency 
(86%) as the unmodified CS protocol.  At 50%, however, the recovery was only 30% 
for the scaled-down protocol vs 47% for the standard one.  In order to mitigate the 
loss of efficiency at higher loading, acetic acid (AA) was added to the lysis buffer 
based on the fact that the magnetic beads require a pH of less than 4.5 to bind nucleic 




raising the efficiency the most, to 50%, the same as that of the standard protocol.  
These results demonstrate that a scaled-down purification can be performed without 
sacrificing efficiency by an appropriate adjustment of the pH. 
 
3.4.2 Enabling GITC Buffer Use in Magnetic Bead-Based Purifications 
The current method to lyse frozen tissues is mechanical grinding followed by the 
application of strong denaturing lysis buffers and then centrifugation or filtering to 
separate remaining tissue fragments.  If the nucleic acids are not separated from tissue 
artifacts, reactions like PCR are inhibited145.   However, grinding, centrifugation, and 
filtering are incompatible with the 2D-RT-PCR protocol, so lysis had to be achieved 
using buffers alone.  The lysis buffer supplied with the ChargeSwitch kit was not 
intended to lyse tissue, and in initial purification tests it in fact did not fully lyse the 
tissue.  This caused the beads to flocculate unpredictably, clogged pipette tips, and 
prevented the beads from being rinsed uniformly.  The beads therefore required 
careful visual inspection for flocculation followed by repipetting to resuspend the 
beads to ensure a successful purification.  Because GITC lysis buffers are more 
aggressive (GITC is a powerful chaotropic denaturant), three different buffers were 
tested to determine whether they were compatible with the CS magnetic beads:  
PicoPure, Qiagen RLT, and a custom buffer.  The concentration of GITC typically 
found in commercial buffers is 4-8 M, but above 4M GITC is known to prevent 
hybridization of nucleic acids146.  Therefore GITC was used at stock concentrations 




hybridization to the magnetic beads.  As in the previous section, the buffers were 
evaluated for purification efficiency at 50% loading with sheared herring DNA.   
 
As shown in the first column of Table 11, none of these buffers was compatible, 
showing efficiencies of only 0% to 5%.   Therefore, the pH was adjusted by adding 
acetic acid or the buffer was diluted four times with water.  The purification 
efficiencies were still poor (columns 2 and 3), ranging from 0% to 19%, with the best 
performance from the custom buffer.  Finally, the buffers were both diluted and pH-
adjusted (column 4).  Under these conditions, the recovery efficiencies rose to 
between 8% and 31%.   
 




75% H2O pH 4.0 
75% H2O + 
pH 4.0 
PicoPure 1% 0% 2% 8% 
Custom 0% 1% 19% 31% 
Qiagen RLT 5% 1% 2% 30% 
 
This is the first demonstration of the use of GITC-based lysis buffer with subsequent 
nucleic acid capture on ChargeSwitch beads.  Even though the ChargeSwitch lysis 
buffer efficiency with pure DNA was higher (47% versus 31% at 50% loading), 
because the GITC based buffer provides more consistent lysis, it may actually 





3.4.3 Single-Well Lysis and Purification on Tissue Samples 
After lysis, commercially-available kits for RNA recovery from solid tissues typically 
transfer the sample from the lysis tube to a second tube for purification and a third for 
amplification.   The lysing and transfers steps are a bottleneck for the isolation of 
nucleic acids, particularly RNA87, 93, 94.  To increase throughput, robotic automation 
or microfluidic chips have been utilized for the transfer steps.  A single-well 
approach, however, would prevent loss of nucleic acids to non-specific binding in 
each tube, decrease the risk of cross-contamination, and reduce processing time. 
 
To determine whether the previously-developed procedures could be performed with 
tissue, thus enabling a single-well lysis and purification protocol, four lysis buffers 
were tested with three different mouse tissue scrapes (brain, kidney, and liver).  The 
ChargeSwitch buffer contained 200 µL lysis buffer, 100 µL binding buffer, and 50 
µL ChargeSwitch magnetic beads.  The others contained 87.5 µL of GITC-based lysis 
buffer during the lysis step, and after lysis buffers were added (59 µL water 100 µL 
ChargeSwitch binding buffer, and 50 µL magnetic beads). 
 
The tissues were incubated in the various buffers at 65 °C for 15 minutes.  The RNA 
was purified as described previously and eluted.  One-step reverse-transcriptase PCR 
reactions were run on 1/60th of each eluted sample to determine the level of HPRT1 (a 
housekeeping mRNA), generating standard curves from which threshold-cycles of 
detection were obtained.  Table 12 shows the relative percent of HPRT1 mRNA, 





Table 12 – Relative effectiveness of single-well lysis and purification using different lysis 
buffers determined by quantitative reverse-transcriptase PCR.   
  Custom Buffer Qiagen RLT PicoPure ChargeSwitch 
Brain 66 100 70 70 
Liver 29 8 4 39 
Kidney 70 17 8 56 
 
For liver and kidney tissues, the PicoPure and Qiagen RLT lysis buffers, which were 
not designed for this system, recovered substantially less HPRT1, with relative 
recoveries of 4% to 17%, compared to the ChargeSwitch and custom GITC lysis 
buffers, which had relative recovery efficiencies of 29% to 70%.  With brain tissue, 
the Qiagen buffer worked the best and the other three were comparable.   
 
Based on visual observation, only the PicoPure and custom GITC buffers fully 
homogenized the tissues and prevented bead flocculation.  However, the PicoPure 
had poor relative recovery of mRNA, and the ChargeSwitch and Qiagen buffers 
required manual removal of undissolved tissue from well.  Therefore, custom GITC 
buffer was the best lysis buffer overall for good relative recovery and ease of tissue 
processing.   
 
3.4.4 Proof of Concept for 2D-PCR  
To demonstrate the feasibility of 2D-PCR, the expression levels of two genes were 
quantified across a tissue section containing frozen mouse brain, mouse kidney, and 
chicken thymus.  Empty wells between mouse tissues served as no-sample controls.  




multiplex PCR reaction was performed using primer and probe targets for KNCJ1, a 
kidney-specific gene, and HPRT1, a housekeeping gene specific to all mouse tissues.  
The KNCJ1 primer/probe set can detect either RNA or DNA.  A detailed protocol is 
provided in Supplemental Information 90.   
 
Figure 24 shows the results.  KCNJ1 was detected only in wells containing mouse 
kidney and HPRT1 only in wells with either mouse tissue.  No false positives were 
detected in any of the negative control wells, demonstrating perfect well sealing 
during the initial lysis, effectiveness of DNase treatment (because no KCNJ1 DNA 
was detected in mouse brain), and the overall cleanliness of this technique.  The Eosin 
Y staining did not affect the subsequent PCR reaction.  This experiment shows that it 










C) Mouse HPRT1 MapB) Mouse KCNJ1 Map
A) Tissue Section
- - - 29.0 28.0 - - -
- - - 28.5 30.0 -
- - - - 27.5 - -
- - - - -
25.5 26.0
25.0 24.0 25.5 25.0
23.5 23.5 25.5
26.5 25.0 - - -
- - - - - - - - - -
 
Figure 24 – A) Mouse brain, mouse kidney, and chicken thymus on an adhesive film, stained red 
with Eosin Y and transferred onto a 384-well plate.  A) The layout of a 384-well format plate is 
outlined over the tissue.  B) KCNJ1 mRNA detection and C) HPRT1 detection showing 
quantitative cycles of detection thresholds (Cts) determined by qPCR. 
 
3.4.5 Identification of the Best Lysis Buffer for 2D-PCR 
The lysis buffers were optimized in section 3.4.3 using tissue scrapes (compacted 
tissues) loaded into the vials, while the 2D-PCR method instead provides tissue held 
flat at the tops of the wells, which may change the lysis performance.  Therefore, 2D-
PCR was used with two different buffer systems, the custom GITC buffer and the 
ChargeSwitch buffer, to map three mRNAs in serial recuts of a tissue section 
containing mouse heart, liver, and kidney.  Tissue sections in these experiments were 




performed using primer and probe targets for KNCJ1, HPRT1, and also GYS2, a 
liver-specific gene.  A detailed protocol is in the Supplemental Information[ESI].    
 
Cts are shown in Figure 25.  HPRT1 was detected in all the wells containing mouse 
tissue, KCNJ1 only in wells with kidney tissues, and GYS2 only in wells with liver 
tissues.  Both lysis buffers worked well.  However, on average KCNJ1, HPRT1, and 
GYS2 were detected 2.3, 1.4, and 0.3 PCR cycles earlier when using the custom 
buffer.  The GITC buffer completely solubilized tissue (Figure 25A2) while the 
ChargeSwitch buffer did not (Figure 25A1).  These results demonstrate that 2D-PCR 
can map three targets at once across a tissue and, based on earlier detection of targets, 
that the custom GITC-based buffer results in greater combined recovery and 























































































A2) Tissue Section 
GITC custom lysis
 
Figure 25 – Two serial recuts of a tissue sample containing mouse brain, kidney, and heart tissue, 
stained red with acid Fuchsin and transferred onto the wells of a 384-well plate containing either 
ChargeSwitch or custom buffer (image of tissue after lysis).  A) The layout of a 384-well format 
plate is outlined over the tissue.  B) KCNJ1 mRNA detection, C) HPRT1 mRNA detection, and 
D) GYS2 mRNA detection showing quantitative cycles of detection thresholds (Cts) determined 






3.5 Discussion and Conclusions 
3.5.1 Single-Well Lysis and Purification  
For the first time, a procedure was developed for using GITC-based lysis buffers with 
ChargeSwitch magnetic beads, which enabled frozen, dried tissue to be fully lysed, 
homogenized, and purified using a single-well protocol.  The protocol developed was 
shown to be as efficient as commercially available bench-top scale reactions, which 
typically require hundreds of microliters of reagents, numerous pipetting steps, and 
multiple transfers between tubes.  The single-well protocol works well with as few as 
5 microliters of starting lysate.  The protocol can thus save a significant amount of 
time and cost for purification and may reduce inconsistencies arising from using 
multiple tubes, for example due to binding of nucleic acids in a tube or purification 
column87-89.  Finally, the custom GITC buffer developed for 2D-PCR outperformed 
the ChargeSwitch lysis buffer in terms of consistency and lower detection thresholds.  
 
3.5.2 2D-RT-PCR 
We have shown an initial proof of concept of 2D-RT-PCR at the resolution of a 384-
well plate, demonstrating that as many as three mRNA targets can be detected in a 
multiplex qPCR reaction.  The technique should have immediate utility with the 
voxelation of tissue6, 7, 18 and high throughput macrodissection and RNA template 




through miniaturization to a sub-millimeter scale and via automation with robotic 
pipetters.   
 
In a multiplex qPCR, a housekeeping gene should be included to account for 
differences in the amount and type of material loaded into each well, providing a 
normalized “delta ct” measurement.  This approach has been validated by others 60, 102.   
 
Using multiplex tandem PCR32-34, it has been shown that up to 92 genes can be 
studied from a single sample of purified mRNA.  This approach may increase the 
number of genes that can be studied across a tissue section.  By converting the RNA 
to pre-amplified DNA, tandem PCR only requires a qPCR step for detection, 
decreasing the costs and reaction times compared to using a one-step RT-qPCR 
protocol.    
 
2D-RT-PCR is expected to complement methods such as LCM and in-situ 
hybridization for validating the expression of mRNA in tissues.  Correlation of 
quantitative mRNA levels with traditional histopathological techniques should lead to 
a greater understanding of the biological roles of mRNA and the identification of 
crucial spatial gene signatures for the clinical diagnosis of diseases such as cancer.   
 
3.5.3 Conclusions 
We have developed a high-throughput technique to quantify the expression of mRNA 




a tissue section using this technique.  A novel single-well protocol for lysing frozen 
tissues with GITC and purifying RNA with ChargeSwitch magnetic beads was 
developed and optimized to enable this approach.  A custom GITC lysis buffer was 
created and was found to detect more mRNA than three other lysis buffers tested. 
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3.7 Electronic Supplementary Information (ESI) 
3.7.1 Primer sequences used in this study 
Table 13 – Primer sequences 
Primer Sets (Biosearch Technologies) 
Target Forward (5’ to 3’) Reverse (5’ to 3’) 
Mouse Liver GYS2 GCCAGACACCTGACACTGA TCCGTCGTTGGTGGTGATG 
Mouse Kidney KCNJ1 GGCGGGAAGACTCTGGTTA GTGCCAGGAACCAAACCTA 
Mouse Control HPRT1 GCAAACTTTGCTTTCCCTGG ACTTCGAGAGGTCCTTTTCACC 
Target Probe (5’ to 3’)   
Mouse Liver GYS2 5'CalFluorOrange560-TTTCCAGACAAATTCCACCTAGAGCCC-BHQ1 
Mouse Kidney KCNJ1 5-FAM-AAGCACCGTGGCTGATCTTCCAGA-BHQ1 
Mouse Control HPRT1 5'Quasar670-CAGCCCCAAAATGGTTAAGGTTGCAAG-BHQ2 
 
 
3.7.2 Specific protocol for duplex mRNA mapping (ChargeSwitch buffer)   
Tissue was thawed at 90 °C for 15 minutes and the film was transferred into a section 
of a 384-well plate covering a 6x5 grid of wells pre-loaded with ChargeSwitch lysis 
buffer, using a sealing time of 2 minutes.  In this experiment, the fluid was distributed 




centrifuge).  After lysis, ChargeSwitch beads and binding buffer was added to each 
well.  Next, a wash was performed using 12.5 µL of wash #14, 6.25 µL of DNase was 
added and incubated for 10 minutes and 2 µL of ChargeSwitch binding buffer (B9) 
was added.  After removing the DNase buffers, two washes were performed using 20 
µL of wash #13 and 12.5 µL of wash #14 buffers.  AgPath-ID one-step RT-PCR mix 
was prepared according to the manufacturer’s protocol.  It included final 
concentrations of 250 nM primers and 125 nM probes for both HPRT1 and KCNJ1 
targets.  Five µL of the PCR mix was added to the 6x5 grid of wells.  The 
thermocycling parameters were 50 °C for 10 minutes, 95 °C for 10 minutes, and 30 
total cycles of 95 °C for 15 seconds and 60 °C for 30 seconds.  The plate was 
removed and imaged on the Typhoon 1410 flatbed scanner every 5 cycles from cycles 
15 to 30. 
 
3.7.3 Specific protocol for triplex mRNA mapping (ChargeSwitch or custom 
GITC buffer) 
Two 5x5 grids within a 384-well plate were pre-loaded with lysis buffer.  The wells 
in one grid were preloaded with a mixture containing 12.5 µL ChargeSwitch lysis 
buffer, 6.25 µL binding buffer, 0.5 µL beads, 0.2 mg/mL proteinase K, 5 mM DTT, 
and acetic acid to a final concentration of 1% by volume.  The wells in the second 
grid were preloaded with 5 µL of custom GITC-based lysis buffer.  The two sections 
on the film were transferred to the 384-well as described in Methods.  The plate was 
inverted, centrifuged, and lysed, and the wells were washed.  AgPath-ID one-step RT-




concentrations of 250 nM primers and 125 nM probes for each of the HPRT1, GYS2, 
and KCNJ1 targets.  7.5 µL of PCR mix was added to the wells containing beads.  
The thermocycling parameters were 50 °C for 15 minutes, 95 °C for 15 minutes, and 
40 total cycles of 95 °C for 10 seconds and 60 °C for 30 seconds.  The plate was 
removed and imaged at cycles 10, 25, 28, 31, 34, 37 and 40 using the Tecan 200 plate 
reader. 
 
3.7.4 Determination of Cts 
It was necessary to perform PCR in a 384-well plate machine but to determine 
fluorescence values using a plate reader to achieve multiplex qPCR data.  An ABI 
7900HT 384-well plate qPCR machine was tested but it was not able to multiplex 
even two colors without spectral overlap.  Therefore the following calculation was 
used to determine Cts based on the standard curve formula. 
 
Fluorescent data was provided at cycles N1-7 = 10, 25, 28, 31, 34, 37 and 40 for the 
triplex mRNA map, or cycles N1-4 10, 20, 25, and 30 for the duplex mRNA map.  In 
order to determine Cts, the difference between two cycles was calculated as Di = 
log(datacycle(Ni+1)/cycle(Ni)), based on the standard curve formula of PCR.  The 
cycle (C1) was determined when Di was greater than a threshold value; thresholds 
defined as 0.04 for KCNJ1, 0.06 for GYS2, and 0.08 for HPRT1.  Finally, the Ct 
value was calculated as C1-A1*Di/0.2 for KCNJ1 and GYS2 or C1-A1*Di/0.25 for 




Based on negative controls and background values, Cts above 30, 32.5, and 35 were 
ignored (for KCNJ1, HPRT1, and GYS2 respectively).  
 
For example, the raw data and calculation to determine the Ct for HPRT1 from a 
single well is presented in Table 14.  In row three, the raw fluorescence data from a 
PCR cycle is divided from the cycle before it and a log operation is performed to give 
the value of Di; because a previous PCR cycle is needed for a baseline, there is no 
value for the first PCR cycle.  Next, the cycle at which Di is above a user-defined 
threshold (.08 for HPRT) is determined to be 28 PCR cycles.  Therefore the value of 
C1 is 28, and because the previous data point was 3 cycles before it, the value of A1 
is 3.  Using the formula for Ct give a value of 25.86, the approximate value at which 
the increase in fluorescent signal was above baseline levels. 
 
Table 14 – Example calculation of Cts from raw data. 
PCR Cycle 10 20 25 28 31 34 37 40
Raw Well Fluorescence Data 2516 2564 2700 4074 6808 9961 11331 12811
Di = log(cycle(Ni+1)/cycle(Ni)) 0.01 0.02 0.18 0.22 0.17 0.06 0.05
Di > .08 threshold? yes





Chapter 4: RNA and microRNA maps from FFPE tissue 
 
In this chapter, the methods and results for mapping and quantifying mRNA and 
microRNA from formalin-fixed tissue sections are presented, as described in aim 3.  
This chapter presents these results as the entirety of a manuscript still in preparation, 
which is expected to be submitted for publication to Nature Methods. 
 
Intellectual contributions:  I drafted the initial manuscript, performed most of the 
experiments, and developed the experimental methodology (see intellectual 
contributions 5-8 in Chapter 7).  I also started and led a collaborative team to work on 
this project, therefore many authors contributed to this work.  These authors’ 
contributions are described here, referring to them by their initials. 
 
BY and AR are two summer students I mentored while at the NCI.  BY performed 
part of the experiments shown in Figure 27A, and helped develop the idea to use 
varying core sizes.  AR performed RecoverAll experiments which comprise half each 
of Figure 27A and C.  KY and JM worked in the TARP lab and manufactured all of 
the TMAs.  JRC validated the pathology of prostate tumor samples.  The co-authors 
(BS, ES, MT, MEB, SH) served an advisory role by guiding the project and helped to 
edit and finalize the manuscript for submission.  ES edited the second figure, and MT 





Quantitative Validation of RNA Expression Profiles in 
Tissue Microarrays 
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Michael Armani, Michael Tangrea, Brian Yang, Alex Rosenberg, Kris Ylaya, 
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4.1 Abstract 
mRNA and microRNA tumor profiles are validated by quantifying the expression of 
dozens of genes against hundreds of samples.  However, current workflows take days 
to complete and require large volumes of formalin-fixed tissue.  We demonstrate a 
faster and more sensitive approach by quantifying the expression of 24 mRNAs in 
duplicate across 42 archival prostate cases by using just one 10 micron-thick tissue 
microarray (TMA) section to validate microarray profiles.  The TMA was transferred 
into a 384-well plate where a single-well lysis and solid-phase purification method 
was used to recover total RNA in each well.  The RNA was assayed directly with 
PCR or indirectly using a Fluidigm assay.  In principle our approach can quantify 96 
mRNAs against 96 cases in less than a day, improving the speed and accuracy of 
traditional workflows such as those used by the MammaPrint or Oncotype DX tests. 
  
4.2 Introduction 
Currently, there is no streamlined technique for validating the expression profiles of 




determined by performing microarray analysis on a few dozen tissue samples.  
Validating the results requires measuring the expression of dozens of genes in 
hundreds of additional cases147.  Normally, each case is studied using a laborious 
four-step workflow whereby tissues are 1) individually sectioned 2) homogenized and 
lysed, followed by 3) RNA purification and 4) RT-qPCR.  The same four steps are 
also used for the diagnostic application of expression profiles, as in the Oncotype DX 
breast cancer assay91.  Although the throughput of RT-qPCR can be improved with 
the Fluidigm and Biotrove platforms, there is no workflow that simplifies the sample 
preparation aspect.  The tissue lysis and RNA purification is recognized as the rate-
limiting step in gene analysis87, 93, 94.  Furthermore, precious tissue is wasted from 
each block to align them during sectioning.  Complicating gene expression profile 
validation is the fact that most archival clinical specimens are formalin-fixed37.  This 
makes it difficult to obtain many high-quality samples for validation.  Using 
formalin-fixed tissues for validation studies necessitates mixing the nucleic acids 
across a large volume of tissue to compensate for RNA degradation.   
 
To address these challenges, we report a new method (Figure 26) that can in principle 
quantify 100s of RNAs in 100s of cases in a single day.  The method transfers a 10 
micron thick tissue microarray section into a 384-well PCR plate and uses a solid-
phase extraction/purification method to prepare RNA from tissue cores.  The RNA 
can be analyzed using traditional PCR techniques or pre-amplified for use with the 
Fluidigm system.  This approach is based on the 2D-PCR method, which was 




shown in Chapter 3.  To recover mRNA, a reverse-crosslinking step was also added.  
To further increase sensitivity, a one-step microRNA RT-qPCR was used to prevent 
the dilution of templates and optimized for use with Fluidigm.   
 
 
Figure 26 – 2D-PCR can be used to validate up to 100 RNAs in multiplex from each core in a 
single 10 micron thick tissue microarray.   
 
4.3 Results and Discussion 
The 2D-PCR method was optimized for detecting microRNA or mRNA from 
formalin-fixed TMA samples.  Speed and sensitivity were compared between 2D-
PCR and a traditional workflow using the commercial RecoverAll kit.  The 
reproducibility of 2D-PCR on serial recuts of tissue was also tested. To demonstrate 
the dynamic range and specificity of 2D-PCR, high-abundance and low-abundance 
mRNA was detected in 5 types of formalin-fixed mouse tissues.  Specificity was also 




specific or human-specific RNA.  Finally, the 2D-PCR technique was used quantify a 
panel of 24 prostate tumor mRNAs from a TMA containing human normal and tumor 
prostate tissues.  By normalizing gene expression to the average of 4 housekeeping 
mRNAs, 15 significant gene profiles were validated. 
 
4.3.1 Speed and sensitivity 2D-PCR vs. a four-step workflow for microRNA 
detection 
The 2D-PCR workflow was compared to the standard workflow of the commercial 
RecoverAll kit, because this kit was widely cited for FFPE RNA recovery.   A TMA 
was made from a single human liver tissue block to provide homogenous tissue cores.  
To assess sensitivity, the TMA included 6 liver cores for each of four different 
diameters (0.6 mm, 1 mm, 1.5 mm, and 2 mm - method 4.5.1).  To perform the 
RecoverAll workflow, a 10 micron TMA section was placed on glass, the 24 cores 
were macrodissected, and the RecoverAll procedure was followed according to the 
manufacturer’s instructions.  To quantify microRNA, a two-step RT-qPCR Applied 
Biosystems microRNA assay was used.  To perform the 2D-PCR procedure, a 10 
micron TMA section was sectioned and transferred into a 384-well plate (method 
4.5.2) and a scaled down single-well lysis and RNA purification protocol was used 
(method 4.5.4).  To transfer TMA’s into 384-well plates, an adhesive was carefully 
selected (see 4.6.2).  MicroRNA quantification was performed directly on the 2D-
PCR templates using a novel one-step microRNA RT-qPCR to detect Mir-191 






The 2D-PCR workflow took about 4 hours, requiring an actual handling time of about 
60 minutes.  The RecoverAll procedure took two work days to complete (about 12 
hours) and required a handling time of about 6 hours.  The 2D-PCR procedure was 
faster because it did not require macrodissection or manual pipetting of samples 
between many tubes.  Based on these results, 2D-PCR is expected to be about an 
order of magnitude faster than a traditional workflow for studying 100s of samples. 
 
Sensitivity 
Using different tissue core sizes allowed us to test the sensitivity of 2D-PCR versus a 
traditional workflow.  For example, a 1 mm diameter tissue should provide 4 times 
less RNA (or 2 Cts) than a 2 mm diameter tissue.  Figure 27A shows the Cts 
determined by each method.  As shown in Figure 27B, the RecoverAll loses RNA 
(higher Cts) as the size of tissue cores decreased, whereas 2D-PCR provided a much 
less steep drop off in Cts.  2D-PCR also had lower variability than RecoverAll.  
These differences can be explained by RNA losses in the RecoverAll purification 
columns and by the dilution of RNA template when using standard two-step 




















































2D-PCR vs. RecoverAll for Small RNA














































Figure 27 – A) Comparison of RecoverAll and 2D-PCR for the recovery of microRNA (mir-191) 
and B) mRNA (SOD2) and smallRNA (RNU48).   Mir-191 is a stable microRNA normalizer
148
.   
Panels C and D show a plot of the measure Cts versus the calculated Cts as predicted by 





4.3.2 Sensitivity 2D-PCR vs. a four-step workflow for mRNA detection 
A similar procedure as in section 4.3.1 was used to compare RecoverAll and 2D-PCR 
workflows for detecting mRNA.  However, a reverse-crosslinking procedure was 
added before the tissue transfer step to extract mRNA with 2D-PCR (method 4.5.3).  
Both procedures used a standard one-step mRNA RT-qPCR procedure (method 4.5.5) 
to detect SOD2 mRNA or RNU48 small RNA.   
 
Figure 27C shows the Cts of detection for SOD2 and RNU48 versus core diameter for 
the two approaches.  The results showed that the RecoverAll did not detect mRNA 
from these samples.  To be sure, RNU48 was quantified.  RNU48 was detected from 
RecoverAll samples, but there was a poor correlation with core diameter (as shown in 
Figure 27D) and it was detected about 10 cycles later than with 2D-PCR.  2D-PCR 
detected mRNA and small RNA with a similar correlation to sample size as detected 
for microRNA.  The variability was also lower using 2D-PCR.   
4.3.3 Reproducibility of 2D-PCR for microRNA and mRNA detection 
SOD2 mRNA and mir-191 microRNA was quantified between two serial recuts of 
TMAs on two different days.  The results showed Pearson R2 correlations of 0.70 to 
0.72 for the microRNA and larger RNAs tested, respectively, therefore 2D-PCR has 
very good assay reproducibility. 
4.3.4 Dynamic range and specificity of 2D-PCR in different tissues 
To demonstrate the dynamic range and specificity of 2DPCR, it was tested on a range 




human tissue network (CHTN) breast samples and high-quality 4-month old mouse 
tissues (brain, liver, kidney, spleen, and lung).  Specific RNAs were quantified from 
serial recuts of this TMA – HPRT1, a low-abundance mouse target, and RNU48, a 
high abundance human target (Table 15).  In another experiment, mRNAs highly-
expressed in mouse liver (GYS2) or mouse kidney (KCNJ1) were mapped in a triplex 
PCR reaction with HPRT1 to show detection specificity and dynamic range for these 
tissues (Figure 30).  Lastly, 2D-PCR was tested using worst-case human autopsy 
samples and decalcified tissues as negative-controls (Figure 31).   
 
The results showed that 2D-PCR can accurately detect mouse or human tissues by 
using PCR and probe sets specific to each species.  The results also showed that at 
least 6 different tissue types could be detected by 2D-PCR.  However, no RNA was 
detected in one of the CHTN samples (Table 15), showing that clinical tissues need to 
be screened for RNA quality before use.  The experimental map of GYS2 and KCNJ1 
targets, normalized to HPRT1, showed the specificity of 2D-PCR for tissue-specific 
mRNA, and also showed a dynamic range of at least 12 cycles of detection across the 
different tissue types (Figure 30).  The results from the autopsy samples showed that 
no RNA could be recovered from decalcified autopsy samples demonstrating the 





Table 15 – Cts of mouse-specific amplification of a low-abundance gene (HPRT1) in well-
controlled FFPE mouse samples that are 4-months old.  Three triplicate samples of human 
breast tissues from the cooperative human tissue network were also used and two showed 
amplification of human-specific small RNA (RNU48). 
   Mouse Brain   Mouse Liver 
Samples   Mouse Kidney   Mouse Spleen 
   Mouse Lung   Human Breast 1 
   Human Breast 2   Human Breast 3 
       
Target 1 28.12 28.07 28.43 29.03 28.61 29.38 
Mouse 28.79 29.75 29.71 28.96 28.43 29.40 
HPRT1 29.83 29.28 29.35 - - - 
 - - - - - - 
       
Target 2 - - - - - - 
Human - - - - - - 
RNU48 - - - 29.24 28.81 29.04 
 - - - 29.32 30.08 29.24 
 
4.3.5 Validation of microarray data using human prostate cancer and normal 
samples 
To validate mRNA expression profiles, a panel of two dozen mRNAs were quantified 
from a TMA containing 25 human prostate tumor and 25 normal prostate samples.  A 
pathologist verified that the majority of the cores were 100% tumor and graded them 
on a Gleason scale from about 5 to 9.  These samples were at least a decade old but 
were known to have good mRNA quality.  As described in methods, the TMAs were 
sectioned onto adhesive film, dewaxed, reverse-crosslinked, transferred to a 384-well 
plate, lysed and the RNA was purified.   
 
A few mRNAs were directly assayed using one-step RT-qPCR.  However, to measure 
the expression of 24 mRNAs in duplicate across many samples required a high-
throughput assay.  Therefore, using a second recut of tissue, total RNA was prepared 




PCR.  A control human RNA dilution series was also pre-amplified.  The pre-
amplified RNA was then assayed using a 48x48 fluidigm plate and an optimized PCR 
supermix was developed to improve the detection of templates in the fluidigm 
system.  The expression of each gene in Cts was normalized to the average of 
expression of four housekeeping genes (B2M, GUS, GAPDH and CYPA) to account 
for differences in total RNA and degradation from each sample33, 91, 102.  The results 
are shown in Figure 28.  The linearity and variability of the pre-amplification and the 
correlation between pre-amplified and directly assayed mRNAs was also determined 
as described in section 4.6.6. 
 
The results showed the validation of several prostate cancer mRNA profiles, 
including the significant (p<.025) overexpression of AMACR, ALCAM, FOLH1, and 
TACSTD1, and the under-expression of ANG, CD69, GSTP1, JAK1, CD10, MUC1, 
SOD2, STAT5B, TIMP3, and VEGF in prostate tumors.  AR, VHL, H1F1A, and 























Figure 28 – Significant differential expression (percent changes determined from Cts, p<.025) of 
14 genes, each normalized to the average of 4 housekeeping genes in 24 prostate tumor cases 





As shown in Section 4.6.6, despite the pre-amplification process, the fluidigm assay 
was consistent and linear.  The Pearson R² linearity of the fluidigm assay on tandem 
RT-qPCR pre-amplified control RNA ranged from 0.9931 to 0.9998 for 21 of the 24 
mRNA targets.  The remaining 3 probe sets had a poor linearity and were dropped 
from the study.  The average standard deviation of Cts was 0.2.   
 
4.4 Discussion 
4.4.1 RNA quality and detection from TMAs 
Formalin-fixed paraffin-embedded (FFPE) tissue is the dominant method of fixation 
in clinics because it allows for high quality histomorphology39.  However, FFPE was 
not originally intended for RNA preservation, thus studies have recently optimized 
FFPE fixation for RNA preservation41, 56.  A TMA consisting of hundreds of samples 
may represent specimens from numerous hospitals with differing fixation procedures.  
Samples should be processed in a similar fashion to reduce artifacts due to the 
fixation method itself96, however the use of a housekeeping gene for normalization 
also allows analysis of samples from different sources33. 
 
RNA quality is also highly dependant on sample preparation and age44.  We showed 
that sensitive detection of low abundance transcripts and high dynamic range is 
possible using 2D-PCR and a reverse-crosslinking treatment on prostate samples over 
a decade old.  Some considerations include using the smallest possible amplicon sizes 
45.  Furthermore, sample dilution should because avoided since below 20 target copies 




used the tandem PCR approach to maximize the concentration of all targets tested.  
Since most microRNA detection scheme require two-step protocols and a 1:15 fold 
dilution, we also introduced a new one-step PCR procedure for quantifying 
microRNA.   
4.4.2 Challenges in the application of TMAs to RNA expression analysis 
Tissue sample/core heterogeneity and divergence from the intended cell types must 
be assessed and considered.  With some tissues, core loss or "drop out" also results in 
the loss of cases for analysis as the TMA block is sectioned deeper.  Therefore, it is 
routine practice to stain and visually check every 50th TMA section to ensure that 
tissue is still present and that the tissue type has not changed.  Despite these issues, 
TMAs provide the best platform today for high-throughput analysis of patient 
samples. 
 
4.4.3 Potential use for Validation Studies and Clinical Diagnosis and Prognosis 
We demonstrated an initial proof of concept for using TMA’s and 2D-PCR as a high-
through sample preparation technique.  We also optimized a one-step pre-
amplification procedure and use of the Fluidigm assay for the detection of dozens of 
mRNAs from dozens of prostate samples.  The most significant impact of this 
approach is that it requires only one 10 micron thick tissue section to detect so many 
mRNAs sensitively.  In principle, this approach could be tailored to clinical 
diagnostic cancer tests that calculate results from less than 96 mRNAs such as the 




existing workflows.  Furthermore, diagnostic tests like MammaPrint and Oncotype 
DX may depend on the fact that tumor specimens have more RNA than the 
surrounding normal tissue92, which allows the use of simple macrodissection 
techniques for sample preparation as opposed to microdissection.  However, van de 
Vjver found that several specimens did not have a sufficiently large proportion of 
tumor cells to use with existing macrodissection workflows and could not be 
diagnosed150.  The use of 2D-PCR may allow more patients or multiple smaller 
tumors from the same patient to be diagnosed because it can use such small volumes 
tissue. 
 
In principle, it is possible to use the TMA, 2D-PCR, and Fluidigm approach to study 
hundreds genes in hundred of patient samples (or many tumors regions from a 
patient) in a single-day.  This would decrease the current diagnostic time of about 5 
days, and possible reduce the costs significantly.  Furthermore, because the approach 
is streamlined, the entire RNA preparation aspect could be automated.  There are no 
other workflows that streamline the quantitative molecular analysis of so many genes 
from so many samples, let alone from archival formalin-fixed specimens.  This 
technique can also be used in principle to detect hundreds of microRNAs by using the 






4.5.1 Crafting of 384-well format TMAs 
Tissue microarrays (shown in Figure 29) were constructed using slight modifications 
of to standard methods. First, a 384 well format grid (Bio-Rad, 384-well hard-skirted 
plates) was cut and customized to fit in an aluminum macro-embedding mold (Leica, 
super metal base molds) approximately 2” x 3” in diameter. The base grid was 
covered in a thin layer of paraffin (Oxford, paraplast X-tra) and allowed to cool to 
room temperature. Next, individual TMA cores of various sizes ranging from 0.6 mm 
to 3.0 mm were extracted from archival tissue blocks and centrally embedded 
vertically into each hole in the grid. Subsequently, the base mold was completely 
filled with paraffin, chilled at 4 °C for 15 minutes, removed and sectioned at 5-10 µm 
thickness using a standard rotary microtome (Leica RM2255).  
4.5.2 Tissue sectioning and transfer to 2D-PCR Plates 
TMA blocks were cut in a microtome onto adhesive films to obtain a uniform 
thickness tissue section for the transfer step.  The film used was Adhesives Research 
ARCare 7759 film (which was selected as shown in Table 16) was placed adhesive-
size against the TMA and pressed with a roller to create consistent contact.  The TMA 
was sectioned at 10 microns thickness, yielding an adhesive bound tissue section.  
The TMA on the adhesive was then dewaxed in fresh xylene for 60 seconds at room 
temperature, and then placed in a fume hood for at least 10 minutes to dry.  The 
adhesive containing TMA cores was then aligned over a clear 384-well flat-top PCR 




plate was then placed in a PTC-200 thermocycler in a special compression rig 100 to 
apply 200 pounds of force and 60 °C to the adhesive for 3 minutes.   
4.5.3 Reverse crosslinking treatment for recovering mRNA 
After dewaxing, tissues were treated in an un-pressurized steam vessel using double-
distilled water for 30 minutes.  Without this treatment, no mRNA recovery was 
possible. Optimization of the reverse-crosslinking treatment is further discussed in 
supplemental materials (section 4.6.5). 
4.5.4 2D-PCR lysis and purification 
Each well of the plate was preloaded with 14 µL of ChargeSwitch lysis buffer 
(Invitrogen ChargeSwitch RNA cell kit) containing 0.2 mg/mL proteinase K and 5 
mM DTT.  After the adhesive film was sealed, the plate was inverted, placed back 
into the compression rig under 200 pounds of force, and heated to 60 °C for 30 
minutes to lyse the tissue.  Alternatively, the procedure was used at 50 °C for 24 
hours to increase the RNA yield (for the prostate tumor TMA) approximately 2-4 
times.  After the lysis, the plate was centrifuged and the adhesive containing residual 
tissue cores was discarded.  A 7 µL solution (containing 0.33 µL ChargeSwitch 
magnetic beads, 1% acetic acid, and 6.6 µL ChargeSwitch binding buffer) was added 
to each well.  Total RNA was bound to the solid phase of the magnetic beads.  The 
magnetic beads were then concentrated using a magnet, and the wells were 
subsequently washed twice with ChargeSwitch wash buffers 13 and 14.  Samples 
containing wash 14 were either used directly in PCR reactions or the wash 14 was 




step RT-qPCR (section 4.5.5) or indirectly by pre-amplification and Fluidigm qPCR 
(section 4.5.6). 
4.5.5 One-step microRNA or mRNA reverse-transcriptase PCR 
To detect microRNA in a single-plex reaction, standard TaqMan microRNA probe 
sets and RT primers were used with a new protocol.  A one-step reverse-transcriptase 
PCR (AgPath ID, ABI) was prepared according to instructions, and microRNA 
probes and primers were both diluted 80-fold in the final reaction volume.  This 
dilution works on the majority of TaqMan probes tested, however some probes need 
to be optimized further.  To detect microRNA in multiplex, custom probe sets (see 
4.6.8) were also created using different colored fluorophores and diluted to the same 
concentration (250 nM primers, 125 nM probes, and 3.125 nM RT primers).  This 
one-step reaction was either added to standard 96-well plates, and 1 µL of wash 14 
containing beads was added to each well.  A similar protocol was followed for 
mRNA.  The reproducibility and PCR efficiency was determined for quantifying 6 
mRNAs as shown in section 4.6.6. 
4.5.6 Tandem mRNA Pre-amplification (to detect up to 100 targets) 
Alternatively, the wash 14 buffer from the previous step was removed from the beads, 
and a pre-amplification mixture was added to the beads, in order to provide the 
maximum concentration of low-abundance targets for multiplexed detection.  The 
pre-amplification procedure is similar to the one used by Stanley32, but was optimized 
to give higher yields and less bias.  One-Step AgPath ID reverse-transcriptase PCR 




much enzyme mix was used, and TaqMan primer/probe sets (see section 4.6.8) were 
diluted 450-fold (to 40 nM) for each primer set.  10 µL of this reaction mix was 
added to each well in the 384-well plate.  The plate was then thermocycled at 50 °C 
for 60 minutes, 95 °C for 15 minutes, and was subjected to 14 cycles of 95 °C for 15 
seconds and 60 °C for 4 minutes.  The final product was diluted 20-fold, and 2 µL 
samples were used in standard qPCR reactions in a real-time PCR machine.  
Alternatively, the templates were diluted only 4-fold for use in the Fluidigm 48x48 
assay.  The linearity of the combination of pre-amplification of a control human RNA 
dilutions followed by quantification by qPCR is shown in section 4.6.7. 
 
4.6 Electronic Supplemental Information (ESI) 
4.6.1 TMAs tested 
Tissues originated from wide range of different preservation qualities, including 
maximum preservation quality from 4-month old mouse samples, high quality 
surgical prostate and liver samples, medium to low quality cooperative human tissue 
network samples, and autopsy samples with cores treated by decalcification to serve 




     
Figure 29 – Overhead view of TMA blocks embedded in paraffin wax with tissue core sizes 
ranging from 0.6 mm to 3 mm.    
 
4.6.2 Selection of adhesive films 
Ten adhesive films were tested for their compatibility with the 2D-PCR approach, 
particularly since xylene is a harsh treatment for most adhesives.  The adhesive film 
needs to be transparent enough to allow visualization of the tissue, it needs to be 
strong enough to adhere to the TMA block during sectioning and dewaxing, the 
adhesive needs to survive the xylene treatments without dissolving, and the adhesive 
needs to maintain its tackiness once the xylene is dried.  To determine the best film, 
sealing was tested on standard 384-well PCR plates which are difficult to seal due to 
the lip over each well, however a flat-top PCR plate is essential to proper sealing and 
allows for more adhesives to seal properly.  Leaks were detected by sealing 
ChargeSwitch lysis buffer plus the addition of eosin dye, and imaging for the dye 
using a Typhoon 1410 flat bed scanner.  The best performing film was ARcare 7759, 
which is an acrylic based adhesive with very high tack; its only disadvantage is that it 
will begin to disintegrate in xylene after about 10 minutes.  A green high-temperature 
silicone (Caswell PCTAPE2) also performed well, and even survived in xylene for at 




McMaster Carr FEP (5804T11) adhesive film also performed well, however polymer 
backing shrank after xylene treatment.   
 
Table 16 – Selection of adhesive film for TMA sectioning, dewaxing, and transfer to 384-well 
plates 
   Sealing Sealing Xylene 
Material Clarity Tack Before After Xylene Max 
ARCare 9020 10mil white acrylic Opaque NO LEAKS - - 
ARCare 90374 10mil gooey Translucent OK LEAKS - Fail 
ARCare 7759 Clear STRONG OK OK 5 min 
ARSeal 90697 Clear NO OK  - - 
Casswell Green Silicone Green Trans STRONG OK OK 24 hr 
Mcmaster Kapton 5mil 2271k73 Orange Trans OK OK LEAKS 24 hr 
McMaster Kapton 1mil 2271571 Dark Orange OK OK WEAK 24 hr 
McMaster PET 8689k42 Clear OK LEAKS - - 
McMaster PTFE 2208T11 Clear OK LEAKS - - 
McMaster FEP 5805T11 Clear STRONG OK OK 2 min 
 
 
4.6.3 Validation of mRNA specificity and dynamic range in mouse tissues in a 
triplex reaction 
To validate the specificity and dynamic range of the 2D-PCR technique, high-quality 
FFPE mouse tissues were amplified using a triplex reaction, which was previously 
tested for specificity on mouse liver, mouse kidney, and all other tissues (see Chapter 
3).  The results show the delta-ct (kidney specific and liver specific genes minus 
housekeeping HPRT1, see 4.6.7 for sequences) demonstrate a wide dynamic range of 
about 12 delta-CTs for both targets.  Indeed, the highest specificity for GYS2 was 






Figure 30 – Demonstration of tissue specific amplification in high-quality mouse FFPE samples 
using a triplex qPCR reaction from the purified template.   Delta Cts are shown.  KCNJ1 (FAM) 
was shown to be highest in Kidney and GYS2 was shown to be highest in Liver as expected.   
There is also a large dynamic range demonstrated which is owed to the high quality of these 
samples. 
 
4.6.4 Worst-Case and negative control tests using autopsy and decalcified tissues 
To validate the sensitivity of the 2D-PCR technique, a TMA was made with random 
autopsy samples, and 4 samples which were heavily decalcified.  Tissues were 
verified independently by a pathologist (JRC).  The results show that even in highly 
degraded autopsy samples, which should not be used for molecular analysis, abundant 
levels of the small RNA RNU48 were detected in most tissues, with a dynamic range 
of about 7 Cts.  As expected, the 4 decalcified samples did not provide RNA because 
decalcification (formic acid) hydrolyses nucleic acids.  However, one brain specimen 
did not provide RNA, as the specimen was fixed for a minimum of two weeks.   
RNU48 DETECTOR
ND ND 25.8 29.3 27.5
28.3 26.9 ND 29.0 25.6
27.3 29.4 28.2 24.5 25.1
26.4 29.6 ND 27.0 29.6
31.7 ND 29.4 28.8 29.3
DecalArtifact DecalBone lymph heart muscle
lung tumor DecalBone muscle few cells
adrenal lung? intestine lymph lymph
brain Skin DecalBone colon many cells
brain brain heart lung heart  
 











4.6.5 Optimization of reverse-crosslinking strategy 
We initially observed that without a heating step, no mRNA was recoverable from 
tissues.  Several reverse-crosslinking were tested to identify the best conditions, 
including dry treatment at 70 °C for 30 minutes, steam treatment for 10, 30, 60, or 
120 minutes, and 10 mM tris 1 mM EDTA bath treatments at 60 °C for 30 minutes or 
125 °C for 15 minutes using a DAKO pressure vessel.  The optimal conditions 
appeared to be a steam treatment in a non-pressurized vessel for 30 minutes.  
Although longer treatments may increase the mRNA yield slightly, there is a risk of 
hydrolysis of low-abundance targets (results not shown). 
 
4.6.6 Pre-amplification linearity and PCR efficiency (Direct PCR – not Fluidigm) 
The one-step mRNA pre-amplification was performed on triplicate samples of human 
esophagus total RNA (BioChain) containing 1000 ng, 125 ng, 15 ng, or 1.5 ng of 
RNA.  The pre-amplified samples were then quantified using qPCR in singleplex, or 
multiplex reactions (with B2M) to provide an internal housekeeping reference gene.  
By determining the PCR efficiency, delta Ct values can be properly adjusted.  As 
shown in Table 17 and Table 18, the results demonstrated good consistency (pearson 
R² ranging from 0.878 to 0.991) for the combination of pre-amplification and 
quantitative PCR.  Furthermore, the results showed that an endogenous (internal 
multiplexed) reference gene could be included as a normalizer without affecting 
linearity much (R² of .931 to 0.977 with multiplex vs R² of 0.98 in singleplex).  The 




greater consistency (R² of .889 to 0.970) than using two reactions (R² of 0.773 to 
0.954). 
Table 17 – PCR efficiency of single-plex amplification after pre-amplification 
 
Target PCR Efficiency % R² Linearity  
VHL 77.5 0.88 
ALCAM 74.7 0.97 
GUS 91.9 0.99 
AMACR 90.9 0.91 
B2M 83.2 0.98 
GAPDH 65.9 0.96 
 
Table 18 – PCR efficiency of B2M as a multiplex endogenous control 
 
Targets PCR Efficiency % R² Linearity 
B2M&VHL 61.8 0.95 
B2M&AMACR 59.4 0.93 
B2M&ALCAM 66.9 0.98 
 
4.6.7 Pre-amplification linearity and PCR efficiency (Fluidigm) 
Linearity was also determined by performing a Fluidigm assay on a dilution series of 
control mRNA subjected to pre-amplification.  To perform a Fluidigm assay, 48 
Taqman probe sets (24 in duplicate) were mixed with Fluidigm loading buffer and a 
custom made PCR mix and added to the assay wells of a 48x48 Fluidigm plate.  The 
PCR mix consisted of 30 mM KCl, 25mM Tris, 3mM MgCl2, 1mM Dithiothreitol,  
0.4mM dNTPs (New England Biolabs) and 0.04 U/µL Dynazyme II DNA 
polymerase.   Then, 48 pre-amplified samples were mixed with Fluidigm loading 
buffer and added to the sample wells of a 48x48 Fluidigm plate.  The samples 






The results showed linearity above 0.98 for all targets and PCR efficiency above 90% 
for all targets.  Therefore, the Fluidigm assay was more consistent and more efficient 
that a standard 384-well PCR.  As a comparison, the Cts for three genes were 
compared between a direct one-step RT-qPCR and an indirect pre-amplification and 
Fluidigm qPCR (see Figure 32).  Despite the differences in assay approach, and the 
fact that the TMA samples used were from 0.5 mm distant recuts, the R2 
reproducibility ranged from 0.57 to 0.72 and is considered to be very good. 
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Figure 32 – Pre-amplification and Fluidigm qPCR vs. direct one-step RT-qPCR assay on 0.5 mm 





4.6.8 Primer Sets Used 
Table 19 – Custom and Taqman probe sets used 
Primer Sets (Biosearch Technologies) 
Target Forward (5’ to 3’) Reverse (5’ to 3’) 
Mouse Liver GYS2 GCCAGACACCTGACACTGA TCCGTCGTTGGTGGTGATG 
Mouse Kidney KCNJ1 GGCGGGAAGACTCTGGTTA GTGCCAGGAACCAAACCTA 
Mouse Control 
HPRT1 GCAAACTTTGCTTTCCCTGG ACTTCGAGAGGTCCTTTTCACC 
Target Probe (5’ to 3’)   
Mouse Liver GYS2 5'CalFluorOrange560-TTTCCAGACAAATTCCACCTAGAGCCC-BHQ1 
Mouse Kidney KCNJ1 5-FAM-AAGCACCGTGGCTGATCTTCCAGA-BHQ1 
Mouse Control 
HPRT1 5'Quasar670-CAGCCCCAAAATGGTTAAGGTTGCAAG-BHQ2 
   
MicroRNA Primer Sets (Biosearch Technologies)  
Target Forward (5’ to 3’) Reverse (5’ to 3’) 
MicroRNA 191 GCCCGCTAGCTTATCAGACTGATG GTGCAGGGTCCGAGGT 
Human RNU48 ATGACCCCAGGTAACTCTGA GAGCGCTGCGGTGAT 
Target Probe (5’ to 3’)   
MicroRNA 191 5'Quasar670-CTAGACTGAGCCAGCT-BHQ2 
Human RNU48 5'Quasar670-TGTGTCGCTGATGCC-BHQ2 
Target RT Primer (5’ to 3’)   
MicroRNA 191 GCTCAGTCTAGTGCAGGGTCCGAGGTATTCGCACTAGACTGAGCCAGCTG 
 
Taqman Gene Expression Assays (20X) ordered from Applied Biosystems.  B2M, Gus, ACTB, 
GAPDH, CYPA, AKT, ALCAM, AMACR, ANG, AR, CD69, FOLH1, GSTP1, H1F1A, HPRT, 





Chapter 5: Discussion and Possible Future Work 
 
 
5.1 Advantages of 2D-PCR 
There are several advantages to 2D-PCR.  Overall, the advantages described in this 
section demonstrate that 2D-PCR is a robust technique, as defined in the aims 
(section 1.4.1).  2D-PCR was found to be sensitive (detecting low-abundance 
mRNAs), consistent (R2 correlation above .70), not prohibitively time-consuming 
(requiring 4 hours), and widely applicable to different tissue types, fixation methods, 
and targets (see Table 20). 
 
One advantage of 2D-PCR is that it can process many tissue samples with the low 
complexity of microdissection methods but allowing for high-throughput and 
sensitivity.  Methods such as LCM and macrodissection ordinarily take days to 
perform an analysis of a few dozen samples18, 102.  For example, as shown in Chapter 
4, a traditional experimental workflow using macrodissection took 16 hours to study 
24 tissue samples, while 2D-PCR took 4 hours and was more sensitive for studying 
the same 24 tissue samples.  2D-PCR was also able to detect low-abundance 
transcripts in formalin-fixed specimens more than 10 years old.  Therefore 2D-PCR is 
sensitive and not prohibitively time-consuming. 
 
Another advantage that is unique to 2D-PCR is the ability to lyse all the subdivided 




of a slide are isolated and processed in a serial process that takes hours.  It is therefore 
possible that when the last sample is studied, so much time has passed that it is 
different than the first sample, for example due to rehydration of the tissue.  With 2D-
PCR, the lysis buffer is inverted onto all tissue subregions at the same time, reducing 
bias and variability.  The overall variability between serial recuts of tissue was 
characterized in Chapter 4, and 2D-PCR between two different tissue samples on two 
different days was very good because it had a Pearson R correlation of 0.84.   
Therefore 2D-PCR is consistent. 
 
Another advantage of 2D-PCR is that it can be applied to a variety of tissue types, 
tissue preservation methods, and nucleic acid targets, as summarized in Table 20.  








Ethanol-Fixed Prostate mRNA, MicroRNA
Formalin-Fixed Prostate mRNA, MicroRNA





Formalin-Fixed Lung mRNA  
Table 20 – Successful application of 2D-PCR to different tissues, fixation methods, and 





5.2 Limitations of 2D-PCR 
There are some limitations to 2D-PCR.  2D-PCR shares the challenge of 
macrodissection in that it cannot achieve cellular-level resolution.  The resolution of 
2D-PCR was demonstrated at 1.6 mm for DNA and 3.7 mm for RNA.  Although 
there is utility for mapping nucleic acids at this resolution (see section 1.3.4), there is  
more potential utility as the resolution decreases.  However, as the size of the wells is 
decreased, the number of wells and pipetting steps increases by a square factor.  At 
some point this may become prohibitive.  However, the transfer step of 2D-PCR does 
not vary with the size of wells and can theoretically be used as-is with different wells 
sizes to control the size of tissue subregions.   
 
Another disadvantage of 2DPCR is that it is unclear if the technique will work with 
pancreas tissue because the pancreas contains the highest amount of nucleases.  The 
highly denaturing GITC buffer used by the method can in theory inactivate nucleases 
in the tissue quickly.  However, the tissue transfer and sealing step requires heat-
activation, which could cause the nucleases to activate.   
 
Another disadvantage of 2DPCR is shared with the existing methods for mapping 
genes in tissue – the genes need to be known prior to analysis.  There is therefore the 
following fundamental contradiction:  a genetic change needs to be identified before 
it can be mapped, but a genetic change needs to be mapped to be identified.  There 
are 20,000 genes, and perhaps only dozens or hundreds are relevant for a given 




the selection.  The problem with microarray methods is that they require a large 
amount of tissue and can only characterize differential expression as significant if it is 
up-regulated or down-regulated by 2-fold.  There is no known solution to this 
problem. 
 
5.3 Possible future work 
There are several ways to improve or use the existing 2D-PCR method.  These 
improvements include increasing resolution (miniaturizing the wells), improving 
handling time, testing new downstream methods, and aiming the technique for 
clinical diagnostic use.   
 
5.3.1 Miniaturization 
To miniaturize 2D-PCR further, a new method of adding and removing buffers is 
needed.  At some point, perhaps at the level of 1 mm, it will become infeasible to 
pipette by hand because of the number of wells and limitations of pipette tip size.  
Even at the scale of 1.6 mm, hundreds of pipetting steps are required.  Therefore the 
use of a robot to improve throughput is desired.  Robots already exist that automate 
pipetting processes in 384-well plates.  At smaller scales, non-contact pipetting robots 
could be used.  These robots can confine a beam of fluid to about 100 µm diameter.   
5.3.2 Simpler purification surface 
Some minimal care is still needed on the part of the user to ensure that the magnetic 




handling of the sample purification in 384-well polypropylene plates, the plastic 
surface should be oxidized to produce a ChargeSwitch surface.  This surface would 
replace the ChargeSwitch microbeads and eliminate the need to use a magnet or to 
wait for the microbeads to be concentrated.  To prepare a charge switch surface on the 
surface of 384-well polypropylene plates, the plastic can be oxidized with potassium 
permanganate and sulphuric acid to yield a carboxylated (i.e. ChargeSwitch) surface 
as described in US patent 691413753.   
 
5.3.3 Other downstream methods 
It is likely that 2D-PCR can be used to detect changes in methylated DNA.  This may 
include a bisulphite modification of the purified DNA followed by qPCR 
(methylation specific PCR35) or an enzymatic treatment that is sensitive to methylated 
DNA followed by qPCR36.  Another possible use of 2D-PCR would be to redesign 
the lysis buffer to recover proteins, carbohydrates, lipids, salts, hormones, or other 
biological components of interest.  2D-PCR would be used to recover the molecules 
while maintaining the 2D layout of a tissue sample.  Traditional techniques like 
chromatography could be used to detect specific targets.  Another possible 
downstream technique to use for detecting nucleic acids includes high-throughput 
detection systems.  These include the Nanostring, Fluidigm, Biotrove, and DNA 
microarray platforms.  
 
Sequencing technologies also have significant potential to increase the number of 




infrequent mutations to be detected.  In the context of 2D-PCR, nucleic acids would 
be purified for use, amplified by PCR, and then used with deep sequencing.  A second 
noteworthy sequencing technique in development is called real-time sequencing using 
single modified polymerases.  This technique has the potential to replace the PCR 
step currently used in 2D-PCR.  All other sequencing technologies are currently not 
fast or inexpensive enough to be practically used with 2D-PCR. 
 
5.3.4 Speculation on the application of 2D-PCR to clinical diagnostics  
2D-PCR could be used in two ways in for medical diagnostics in the near future.  For 
example, the oncotype DX test already uses macrodissection and large sample 
volumes as described in section 1.3.4.  Therefore it is possible to use 2D-PCR to 
improve the processing time and handling ease of the oncotype DX test.  The test 
costs $4000, a price that could be reduced using 2D-PCR if labor and consumable 
cost are major factors.  Another way 2D-PCR could improve the diagnostic test is by 
reducing the amount of tissue needed to run diagnostic tests.  This is described in the 
discussion of Chapter 4. 
 
A second way 2D-PCR could be used is to examine tumor margins after a tumor 
resection.  Normally, the tumor margins are examined by a pathologist to ensure that 
there are no tumor cells left in the patient after surgery.  However, it is possible that a 
few cells are present and the pathologist misses the tumor cells by visual inspection, 
or it is possible that there are cells that look normal but harbor genetic mutations that 




order to perform such a diagnostic test, it would need to give results within an hour so 
it can be done conveniently during surgery.  This is possible in theory as 2D-PCR is 
amenable to robotic automation for the sample preparation aspect, and others have 
demonstrated micro-scale PCR systems that can quantify nucleic acids in less than 10 
minutes.  The speed of 2D-PCR could therefore be improved, whereas the other 
method methods have no streamlined protocol that could be hastened 
(macrodissection, LCM) or have no potential for results in less than an hour (ISH).  
 
5.3.5 Immediate applications of 2D-PCR 
2D-PCR as presented in this thesis can be applied to improve the throughput of two 
specific molecular biology studies.  Human brain samples may be mapped by 2D-
PCR to improve the voxelation method7, 18, which is based on macrodissection.  2D-
PCR could also prepare mouse and rat brains RNA for “high-resolution voxelation”18 
by using a 1534-well plate, but the qPCR would need to be performed in another 
device because there are no 1534-well plate qPCR instruments.  Another useful 
application would be to study tumor samples and compare against normal tissues 
using a tissue microarray format – providing a high-throughput tool for gene 
validation as demonstrated in Chapter 4.   
 
Another immediate application would be to improve the throughput of LCM and 
macrodissection sample processing.  Typically, LCM samples are placed on a cap, 
and processed using a serial workflow for each sample.  The single-well lysis and 




LCM samples in a batch process, and may improve the nucleic acid recovery because 





Chapter 6: Conclusion and Technical Developments 
 
A new approach for detecting or quantifying nucleic acids in tissues called 2D-PCR 
has been developed.  2D-PCR preserves the 2D layout of a tissue sample by first 
dividing the tissue into subregions.  2D-PCR was applied to a variety of nucleic acid 
targets in different tissue types, which were preserved using a variety of methods, as 
summarized in Table 20.  DNA was extracted, amplified by PCR, and detected using 
DNA-specific dyes.  RNA was extracted, purified, and quantified using qPCR.   
 
The new knowledge contributed by this thesis includes three 2D-PCR protocols and 
the technical developments that enabled each of these protocols.  The protocols were:  
1) detecting one DNA target in a frozen tissue section, 2) quantifying up to three 
mRNAs in a frozen tissue section, and 3) quantifying up to 24 mRNAs in a formalin-
fixed tissue microarray section.  These developments were used successfully to 
overcome a series of difficult issues, as described in Chapter 7.    
 
The first 2D-PCR protocol divided a frozen tissue section at a resolution of a 1.6 mm 
into an aluminum multi-well plate.  DNA in each well was extracted using an 
optimized proteinase K buffer, the extracted DNA was amplified by PCR, and the 
amplified DNA was detected using a DNA-specific dye.  To enable this 2D-PCR 
protocol, it was determined that the tissue could be stained by eosin dye to visualize 




tissue sections onto an adhesive film for subsequent handling and sealing was 
developed.  Also, a compression rig providing 150 psi of pressure was built to press 
this tissue into the multi-well plate to in one step, subdividing the entire tissue section 
it and loading it into the wells for subsequent processing.  In order to extract the DNA 
without affecting the PCR step, it was determined that proteinase K could extract 
DNA without buffers, and that the proteinase K could be inactivated and dried using 
high temperature.  In order to keep DNA from spreading between wells, a method of 
using 2% LMP agarose added to the solution in the wells was developed that 
immobilized the DNA, yet did not inhibit  DNA extraction or PCR.  In order to 
prevent the inhibition of PCR due to the presence of aluminum, 0.1% BSA was 
identified as a PCR enabling additive.  In order to prevent the heat of thermocycling 
during PCR from evaporating the reagents, the adhesive tape was utilized as a sealing 
film, applied using the compression rig.  A reversible sealing film was selected to 
allow access to the amplified DNA for staining.   
 
The second 2D-PCR protocol divided a frozen tissue into part of a 384-well PCR 
plate with a well size of 3.7 mm.  To enable this protocol, a novel single-well tissue 
lysis and nucleic acid purification protocol was developed based on the ChargeSwitch 
proteinase K lysis and magnetic bead purification.  This single-well protocol was then 
modified to allow the use of GITC lysis buffer, which fully solubilizes frozen tissue 
samples, preventing clogging, and providing more uniform nucleic acid recovery.  




recovery.  In order to visualize tissues during the transfer without affecting qPCR, 
many tissue-specific stains were tested.    
 
The third 2D-PCR protocol divided a formalin-fixed tissue microarray into part of a 
384-well PCR plate with a well size of 3.7 mm.  A transfer film was rigorously 
selected in order to section formalin-fixed tissues, dewax them, and transfer and seal 
the section into a 384-well plate.  A reverse-crosslinking step was optimized for 
recovering mRNA from formalin-fixed specimens.  A one-step microRNA RT-qPCR 
procedure was also developed, eliminating the dilution step of traditional two-step 
processes to allow the detection of low-abundance microRNAs sensitively.  Finally, a 
one-step tandem RT-PCR was optimized for amplifying 24 targets in multiplex, and a 
matching qPCR reagent was developed for detecting the genes efficiently using the 








Chapter 7: Intellectual Contributions 
 
Many challenges or constraints were overcome in order to produce the results shown 
in chapters 2-4 and to prove the concept behind 2D-PCR.  These intellectual 
contributions/technical developments are explained below. 
7.1 Contribution 1 – Cutting tissues into subregions 
Before 2D-PCR, the only methods for cutting tissues into subregions were laser 
cutting methods and voxelation, which uses a garlic slicer like device to cut thick 
tissues.  No methods provided a way to subdivide thin tissue sections and maintain 
the layout of the sample.  2D-PCR solved this problem using a 4-step protocol.  1) 
tissues were sectioned and placed on a heat activated sealing film.  Heat-activated 
sealing film was chosen after significant trial and error.  2) Once on the sealing film, 
the tissue was immediately dried to prevent movement or degradation of the tissue.  
3) The dried tissue was aligned over a grid of wells.  4) The tissue was then forced 
into the grid using a compression and heating apparatus.  This step cut the tissue into 
subregions.  After much trial and error it was also discovered that the grid of wells 
needs to have a flat top to create a good seal.   
7.2 Contribution 2 – Lysis of frozen tissue for DNA recovery 
No methods existed before 2D-PCR for lysing DNA from frozen samples in a single-
well method.  It was discovered that proteinase K is a robust enough enzyme to 




proteinase K could be heat-inactivated and the buffer could be dried and resuspended 
with PCR reagents for a streamlined solution. 
 
Another problem was that the PCR and proteinase K steps required high-temperature 
incubations that would cause the reagents to evaporate.  Therefore, a sealing film and 
compression strategy was developed to prevent the loss of reagents due to 
evaporation.  However, the sealing film needs to be removed to allow the dehydration 
of proteinase K, which allows PCR reagents to be added in a future step.  Therefore 
sealing film was selected that could be reversibly sealed.  Another problem with seal 
remove was that fluid would wick between wells by surface tension when the sealing 
film was removed.  Therefore it was determined that 2% agarose could be added to 
prevent the diffusion of DNA.  During the proteinase K step, the heat of the 
incubation melts and distributes the agarose throughout the well. 
7.3 Contribution 3 – Visualization of tissue 
2D-PCR needed a method to determine where a tissue section was placed, i.e., to 
figure out which wells had tissue transferred into them.  Two dyes (eosin and acid 
fuchsin red) were found to stain tissues pink so that the tissue could be visualized, and 
these dyes did not inhibit PCR.  However, eosin is much more fluorescent than 
fuchsin red, so fuchsin red is better for qPCR and better overall for use with 2D-PCR. 
7.4 Contribution 4 – Lysis and purification of RNA from frozen samples 
No methods existed before 2D-PCR for lysing frozen tissues and purifying RNA in a 




were that RNA quality will degrade if the tissue is not lysed completely, and tissue 
fragments that are not lysed completely will stick to and clog purification surfaces.  
The major breakthrough was identifying the right amount of water and acid to add to 
GITC-based buffers so that tissue samples could be lysed completely, but still allow 
mRNA purification on magnetic beads.  In effect, tissues are completely liquefied by 
2D-PCR, and then the RNA is purified from the lysates in a single-tube procedure, 
allowing the layout of a sample to be maintained.  No GITC based buffers had 
previously been reported for use with ChargeSwitch beads. 
7.5 Contribution 5 – Dewax formalin-fixed tissues on adhesive films  
No methods existed before 2D-PCR for sectioning formalin-fixed and paraffin 
embedded tissues onto adhesive films, treating the films with xylene, and maintaining 
the adhesive properties of the film.  Ten films were tested before one was found that 
was ideal for dewaxing tissues in xylene but that also retained enough tack to prevent 
fluid loss from the wells of a 384-well plate.  It was also crucial to use flat-top PCR 
plates to maintain a consistent seal. 
7.6 Contribution 6 – Lysis of formalin-fixed tissue for RNA recovery 
Another key development for 2D-PCR of formalin-fixed samples was the 
optimization of a reverse crosslinking step for tissues on adhesive films.  Placing the 
samples in a steamer for 30 minutes provided the ideal balance between RNA 
recovery and RNA loss.  Previously published techniques that suggested placing 




Without reverse cross-linking, it was impossible to recover mRNA from a formalin-
fixed sample. 
7.7 Contribution 7 – Studying microRNA without dilution 
Existing methods for microRNA amplification by PCR required two steps.  The two-
step procedure dilutes microRNA by a factor of 15.  For low-abundance targets, this 
can make the difference between inconsistent and consistent detection in a qPCR 
reaction (see Poisson effect 1.2.3.3).  Therefore a new procedure was developed to 
perform microRNA amplification in a one-step process so that template was not 
diluted.  The optimal technique was experimentally determined so that microRNA 
could be detected without false positives. 
7.8 Contribution 8 – Studying nucleic acids in multiplex 
In order to maximize the throughput from small volumes of sample, a multiplexing 
method was tested and optimized.  Tandem PCR was used to pre-amplify 28 mRNA 
targets at the same time.  This approach maintains the concentration of mRNA in a 
sample to reduce the variability caused by dilute templates.  The tandem PCR was 
optimized to provide maximum recovery by extending reaction times and increasing 
the amount of reverse transcriptase in the reaction.  After tandem PCR, a Fluidigm 
chip was use to study many samples and many genes in a single day.  However, the 
PCR reagents recommended by Fluidigm demonstrated PCR inhibition due to weak 
efficiency.  Therefore a novel PCR mixture was optimized for use with the pre-





Chapter 8: Appendices 
 
8.1 2D-PCR Publications and presentations 
1. M. Armani, J. Rodriguez-Canales, J. Gillespie, M. Tangrea, H. Erickson, M. 
R. Emmert-Buck, B. Shapiro, and E. Smela, "2D-PCR: A method of mapping 
DNA in tissue sections," Lab Chip, 9(24), 3526 - 3534 (2009). 
2. Michael Armani, Mike Emmert-Buck, Elisabeth Smela, Ben Shapiro, Mike 
Tangrea, Jaime Rodriguez-Canales, Rodrigo Chuaqui  “Amplification 
Platform and Methods of Use Thereof,” submitted to the USPTO on 1/30/10;  
This patent is currently undergoing licensing negotiations with 2D-BIO LLC. 
3. Michael Armani - Podium Presentation, "Mapping DNA in Tissues: A 
Spatially Resolved Array Technique with Integrated Tissue Transfer, DNA 
Extraction, Amplification and Detection," Lab-on-a-Chip World Congress, 
San Francisco, USA 6th & 7th August, 2009.  Chaired new technologies 
session. 
4. Michael Armani - Podium Presentation, NIH Graduate Partnership 
Program Retreat, Flintstone, MD 16th & 17th July, 2009. 
5. Michael Armani - Podium Presentation, UMMC Hormone Responsive 
Cancers Program, Baltimore, MD 3rd April, 2009 
6. Michael Armani - Poster Presentation, UMD Bioengineering Fischell 
Festival, College Park, MD 21st April, 2009.  
7. Michael Armani - Poster Presentation, Tenth Principal Investigator’s (PI) 
Innovative Molecular Analysis Technologies Program, Bethesda MD 7th to 
9th October, 2009. 
8. Michael Armani - Awarded NIH technology transfer awards in 2009 and 
2010. 
Manuscripts drafted: 
9. M. Armani, M. Tangrea, B. Shapiro, E. Smela, M. R. Emmert-Buck. 
"Quantifying mRNA across a Histological Section with 2D-PCR" to be 
submitted to Nucleic Acids Research, Methods Online. 
10. M. Armani, M. Tangrea, B. Yang, A. Rosenberg, K. Ylaya, J. Martinez, J. 
Rodriguez-Canales, B. Shapiro, E. Smela, M.R. Emmert-Buck, and S. Hewitt. 
"Quantitative Validation of RNA Expression Profiles in Tissue Microarrays" 





8.2 Single-well lysis & purification compared to existing methods 
In this section, the single-well RNA lysis and purification workflow used in 2D-PCR 
is compared with 4 common commercially available kit based methods.  These 
commercial kits are based on the methods described in section 1.2.5.  This section 
assumes all methods start with a tissue section scrape.  In summary, all of the 
available techniques require at least 3 tubes for lysis, but the 2D-PCR lysis and 
purification method is a novel approach to purifying template in a single well/tube. 
1. Addition of Sample
2. Sample Lysis and RNase inactivation
3. Sample Homogenation
5. Pipette Out Top Phase
7. Removal of DNA




8. Aliquot SampleTube C
4. RNA isolation by phase separation
Phase Separation Based Method
1. Addition of Sample
3. Removal of DNA
4. Purification of RNA
5. Detection Step
2. Sample Lysis, Homogenation, 
RNase Inactivation, RNA 
Precipitation, and RNA capture
Tube A
Single-well Lysis and Purification
 
Figure 33 – Comparison between Invitrogen Trizol, based on the Chomzinski method, and 2D-PCR’s 





1. Addition of Sample
2. Sample Lysis and RNase Inactivation
5. Transfer RNA Precipitate
7. Removal of DNA








10. Aliquot SampleTube D
Tube C
1. Addition of Sample
3. Removal of DNA
4. Purification of RNA
5. Detection Step
2. Sample Lysis, Homogenation, 
RNase Inactivation, RNA 
Precipitation, and RNA capture
Tube A
Single-well Lysis and PurificationSilica Filter Based Method RNeasy
 
Figure 34 – Comparison between Qiagen RNeasy, based on the GITC lysis and silica column 





2. Sample Lysis, RNase Inactivation, 
and Sample Homogenization
Silica Filter Based Method PicoPure
1. Addition of Sample
4. Transfer RNA Precipitate
6. Removal of DNA







9. Aliquot SampleTube D
Tube C
1. Addition of Sample
3. Removal of DNA
4. Purification of RNA
5. Detection Step
2. Sample Lysis, Homogenation, 
RNase Inactivation, RNA 
Precipitation, and RNA capture
Tube A
Single-well Lysis and Purification
 
Figure 35 – Comparison between Picopure RNA extraction kit, based on the GITC lysis and silica 





1. Addition of Sample
6. Add Sample From Step 4
8. Pipette Buffers Out





3. Sample Lysis, RNase Inactivation
4. Sample Homogenation
5. Prepare RNA Capture Beads
Magnetic Oligo-dT Beads
10. Detection Step
9. Aliquot SampleTube C
1. Addition of Sample
3. Removal of DNA
4. Purification of RNA
5. Detection Step
2. Sample Lysis, Homogenation, 
RNase Inactivation, RNA 
Precipitation, and RNA capture
Tube A
Single-well Lysis and Purification
 
Figure 36 – Comparison between Invitrogen Dynabeads magnetic bead purification kit, based on the 
lithium chloride based lysis and oligo-dT magnetic bead purification methods, and 2D-PCR’s single-
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